Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression
Like a set of bookends, cellular, molecular, and genetic changes of the beginnings of life mirror those of one of the most common cause of death—metastatic cancer. Epithelial to mesenchymal transition (EMT) is an important change in cell phenotype which allows the escape of epithelial cells from the...
Saved in:
| Published in | Journal of cellular physiology Vol. 213; no. 2; pp. 374 - 383 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.11.2007
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Like a set of bookends, cellular, molecular, and genetic changes of the beginnings of life mirror those of one of the most common cause of death—metastatic cancer. Epithelial to mesenchymal transition (EMT) is an important change in cell phenotype which allows the escape of epithelial cells from the structural constraints imposed by tissue architecture, and was first recognized by Elizabeth Hay in the early to mid 1980's to be a central process in early embryonic morphogenesis. Reversals of these changes, termed mesenchymal to epithelial transitions (METs), also occur and are important in tissue construction in normal development. Over the last decade, evidence has mounted for EMT as the means through which solid tissue epithelial cancers invade and metastasize. However, demonstrating this potentially rapid and transient process in vivo has proven difficult and data connecting the relevance of this process to tumor progression is still somewhat limited and controversial. Evidence for an important role of MET in the development of clinically overt metastases is starting to accumulate, and model systems have been developed. This review details recent advances in the knowledge of EMT as it occurs in breast development and carcinoma and prostate cancer progression, and highlights the role that MET plays in cancer metastasis. Finally, perspectives from a clinical and translational viewpoint are discussed. J. Cell. Physiol. 213: 374–383, 2007. © 2007 Wiley‐Liss, Inc. |
|---|---|
| AbstractList | Like a set of bookends, cellular, molecular, and genetic changes of the beginnings of life mirror those of one of the most common cause of death—metastatic cancer. Epithelial to mesenchymal transition (EMT) is an important change in cell phenotype which allows the escape of epithelial cells from the structural constraints imposed by tissue architecture, and was first recognized by Elizabeth Hay in the early to mid 1980's to be a central process in early embryonic morphogenesis. Reversals of these changes, termed mesenchymal to epithelial transitions (METs), also occur and are important in tissue construction in normal development. Over the last decade, evidence has mounted for EMT as the means through which solid tissue epithelial cancers invade and metastasize. However, demonstrating this potentially rapid and transient process in vivo has proven difficult and data connecting the relevance of this process to tumor progression is still somewhat limited and controversial. Evidence for an important role of MET in the development of clinically overt metastases is starting to accumulate, and model systems have been developed. This review details recent advances in the knowledge of EMT as it occurs in breast development and carcinoma and prostate cancer progression, and highlights the role that MET plays in cancer metastasis. Finally, perspectives from a clinical and translational viewpoint are discussed. J. Cell. Physiol. 213: 374–383, 2007. © 2007 Wiley‐Liss, Inc. Like a set of bookends, cellular, molecular, and genetic changes of the beginnings of life mirror those of one of the most common cause of death--metastatic cancer. Epithelial to mesenchymal transition (EMT) is an important change in cell phenotype which allows the escape of epithelial cells from the structural constraints imposed by tissue architecture, and was first recognized by Elizabeth Hay in the early to mid 1980's to be a central process in early embryonic morphogenesis. Reversals of these changes, termed mesenchymal to epithelial transitions (METs), also occur and are important in tissue construction in normal development. Over the last decade, evidence has mounted for EMT as the means through which solid tissue epithelial cancers invade and metastasize. However, demonstrating this potentially rapid and transient process in vivo has proven difficult and data connecting the relevance of this process to tumor progression is still somewhat limited and controversial. Evidence for an important role of MET in the development of clinically overt metastases is starting to accumulate, and model systems have been developed. This review details recent advances in the knowledge of EMT as it occurs in breast development and carcinoma and prostate cancer progression, and highlights the role that MET plays in cancer metastasis. Finally, perspectives from a clinical and translational viewpoint are discussed. |
| Author | Lawrence, Mitchell G. Williams, Elizabeth D. Thompson, Erik W. Blick, Tony Clements, Judith A. Hugo, Honor Ackland, M. Leigh |
| Author_xml | – sequence: 1 givenname: Honor surname: Hugo fullname: Hugo, Honor organization: Embryology Laboratory, Murdoch Children's Research Institute, The Royal Children's Hospital, Victoria, Australia – sequence: 2 givenname: M. Leigh surname: Ackland fullname: Ackland, M. Leigh organization: Centre for Cellular and Molecular Biology, Deakin University, Victoria, Australia – sequence: 3 givenname: Tony surname: Blick fullname: Blick, Tony organization: VBCRC Invasion and Metastasis Unit, St. Vincent's Institute, Victoria, Australia – sequence: 4 givenname: Mitchell G. surname: Lawrence fullname: Lawrence, Mitchell G. organization: School of Life Sciences and Institute of Health and Biomedical Innovation, Queensland University of Technology, Queensland, Australia – sequence: 5 givenname: Judith A. surname: Clements fullname: Clements, Judith A. organization: Centre for Cancer Research, Monash Institute of Medical Research, Monash University, Victoria, Australia – sequence: 6 givenname: Elizabeth D. surname: Williams fullname: Williams, Elizabeth D. email: elizabeth.williams@med.monash.edu.au organization: Centre for Cancer Research, Monash Institute of Medical Research, Monash University, Victoria, Australia – sequence: 7 givenname: Erik W. surname: Thompson fullname: Thompson, Erik W. organization: The University of Melbourne Department of Surgery, St. Vincent's Hospital, Victoria, Australia |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/17680632$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kMtOwzAURC1URB-w4AdQVkgs0vqRxPESVW2hVDxEKUvLcR3qkjjBTgX9ewIphQ2rq9GcmStNF7RMYRQApwj2EYR4sJZlHyOMyQHoIMioH0QhboFO7SGfhQFqg65zawghY4QcgTaiUQwjgjtgMSp1tVKZFpmfK6eMXG1zkXnCLL0_2ld7zKusME5XujDO08aTwkptilx4pS1erHKudo7BYSoyp052tweexqP58Mqf3U2uh5czXwYRJj4VCYUwUiGhTNUihYFgmCCaJCRhjMUBY2KZQCYTIqlM41SKGFEoUhZJmSDSA-dNb_37baNcxXPtpMoyYVSxcTyKMY6DOK7BiwaUtnDOqpSXVufCbjmC_GtEXo_Iv0es2bNd6SbJ1fKX3K1WA4MGeNeZ2v7fxKfD-59Kv0loV6mPfULYVx5RQkP-fDvhs-nj4mY8n_MH8gkyDI63 |
| CitedBy_id | crossref_primary_10_1007_s12307_012_0098_7 crossref_primary_10_1016_j_cellsig_2018_01_012 crossref_primary_10_1038_modpathol_2009_19 crossref_primary_10_1155_2011_249290 crossref_primary_10_1186_s12964_015_0106_x crossref_primary_10_1186_s12967_017_1275_8 crossref_primary_10_1007_s10620_014_3121_7 crossref_primary_10_1186_1476_4598_10_139 crossref_primary_10_1038_onc_2011_330 crossref_primary_10_1186_1757_2215_7_76 crossref_primary_10_3390_biom11081197 crossref_primary_10_1158_0008_5472_CAN_08_2093 crossref_primary_10_1177_03009858221117858 crossref_primary_10_1007_s00432_011_1099_5 crossref_primary_10_1007_s10555_016_9626_0 crossref_primary_10_1634_theoncologist_2009_0094 crossref_primary_10_1016_j_bbcan_2012_03_002 crossref_primary_10_1002_pros_23404 crossref_primary_10_1038_onc_2012_494 crossref_primary_10_1158_0008_5472_CAN_07_2017 crossref_primary_10_1371_journal_pone_0077400 crossref_primary_10_1007_s12307_008_0007_2 crossref_primary_10_1002_ijc_25151 crossref_primary_10_1016_j_prp_2023_155068 crossref_primary_10_1002_cyto_a_22244 crossref_primary_10_1186_s13058_017_0880_z crossref_primary_10_1186_s13287_015_0003_7 crossref_primary_10_1111_cas_12171 crossref_primary_10_1074_jbc_M113_480285 crossref_primary_10_7314_APJCP_2013_14_9_5055 crossref_primary_10_3389_fcell_2020_585619 crossref_primary_10_18632_oncoscience_92 crossref_primary_10_1186_bcr3367 crossref_primary_10_12659_MSM_893412 crossref_primary_10_1080_01635581_2022_2027473 crossref_primary_10_1007_s10555_012_9387_3 crossref_primary_10_1007_s10555_010_9239_y crossref_primary_10_1074_jbc_M705759200 crossref_primary_10_18632_oncotarget_26678 crossref_primary_10_1096_fj_10_162677 crossref_primary_10_3389_fphar_2017_00267 crossref_primary_10_1158_1535_7163_MCT_09_1106 crossref_primary_10_1016_j_gamo_2016_02_003 crossref_primary_10_1016_j_ejso_2021_07_009 crossref_primary_10_1007_s12253_017_0320_5 crossref_primary_10_1371_journal_pone_0221270 crossref_primary_10_1038_s41598_019_44412_y crossref_primary_10_1002_hed_21638 crossref_primary_10_1007_s10585_009_9242_2 crossref_primary_10_1016_j_bbcan_2009_03_002 crossref_primary_10_1038_s41419_020_03340_w crossref_primary_10_1038_onc_2012_466 crossref_primary_10_1248_bpb_b20_00654 crossref_primary_10_3892_or_2013_2909 crossref_primary_10_1186_1476_4598_9_179 crossref_primary_10_1111_his_12435 crossref_primary_10_1186_s12967_015_0425_0 crossref_primary_10_1097_IGC_0000000000000761 crossref_primary_10_1158_0008_5472_CAN_08_3198 crossref_primary_10_1016_j_canlet_2020_12_025 crossref_primary_10_1016_j_freeradbiomed_2014_07_032 crossref_primary_10_1016_j_modpat_2022_100082 crossref_primary_10_1371_journal_pone_0018878 crossref_primary_10_1016_j_ceb_2018_06_008 crossref_primary_10_1186_bcr3580 crossref_primary_10_1007_s10555_013_9488_7 crossref_primary_10_1002_jcp_24806 crossref_primary_10_1038_modpathol_2009_33 crossref_primary_10_1097_PAI_0b013e3181e8d54b crossref_primary_10_1155_2015_697395 crossref_primary_10_1007_s00204_021_03196_9 crossref_primary_10_1364_BOE_2_002307 crossref_primary_10_3892_ijo_2018_4325 crossref_primary_10_1136_gutjnl_2016_312927 crossref_primary_10_1155_2020_3256538 crossref_primary_10_7704_kjhugr_2015_15_3_155 crossref_primary_10_1371_journal_pone_0003368 crossref_primary_10_1002_ijc_27368 crossref_primary_10_1016_j_yexcr_2014_05_019 crossref_primary_10_1074_jbc_M803375200 crossref_primary_10_1186_s12943_021_01321_x crossref_primary_10_1007_s12282_021_01221_4 crossref_primary_10_4161_cbt_22625 crossref_primary_10_1002_cam4_6543 crossref_primary_10_1007_s11060_016_2236_4 crossref_primary_10_1016_j_phrs_2019_104390 crossref_primary_10_1016_j_canlet_2014_05_022 crossref_primary_10_1007_s12307_014_0148_4 crossref_primary_10_1007_s10585_012_9527_8 crossref_primary_10_1158_0008_5472_CAN_08_4470 crossref_primary_10_1007_s10585_008_9186_y crossref_primary_10_18632_oncotarget_634 crossref_primary_10_1007_s11605_015_2767_6 crossref_primary_10_1186_bcr3217 crossref_primary_10_1371_journal_pone_0075489 crossref_primary_10_1038_bjc_2015_10 crossref_primary_10_1158_0008_5472_CAN_15_1326 crossref_primary_10_1186_s43094_021_00368_3 crossref_primary_10_1016_j_molonc_2010_06_007 crossref_primary_10_3390_md18060314 crossref_primary_10_1186_s12967_022_03457_w crossref_primary_10_1016_j_febslet_2012_04_009 crossref_primary_10_3892_ijo_2012_1541 crossref_primary_10_37349_etat_2021_00046 crossref_primary_10_1088_1478_3975_abf425 crossref_primary_10_1007_s10911_010_9175_z crossref_primary_10_3892_ijo_2014_2464 crossref_primary_10_1016_j_cell_2011_02_013 crossref_primary_10_1016_j_bbcan_2012_04_008 crossref_primary_10_1186_1476_4598_10_87 crossref_primary_10_1186_1471_2407_13_432 crossref_primary_10_1007_s00432_014_1809_x crossref_primary_10_1007_s10911_010_9174_0 crossref_primary_10_1111_1759_7714_12776 crossref_primary_10_1007_s00432_014_1752_x crossref_primary_10_1158_1541_7786_MCR_16_0011 crossref_primary_10_1016_j_pbiomolbio_2019_08_001 crossref_primary_10_1186_s12885_016_3007_5 crossref_primary_10_1016_j_rvsc_2014_09_014 crossref_primary_10_1186_1471_2407_12_10 crossref_primary_10_1371_journal_pone_0051044 crossref_primary_10_1007_s00428_010_1033_2 crossref_primary_10_1186_s13287_018_1129_1 crossref_primary_10_1186_1471_2407_12_35 crossref_primary_10_1203_PDR_0b013e31816a7453 crossref_primary_10_1002_ijc_28471 crossref_primary_10_1007_s13277_013_1185_1 crossref_primary_10_1242_jcs_045997 crossref_primary_10_1371_journal_pone_0017507 crossref_primary_10_1016_j_biopha_2018_11_112 crossref_primary_10_1007_s12079_011_0117_3 crossref_primary_10_1089_hum_2013_177 crossref_primary_10_1093_humrep_der442 crossref_primary_10_3389_fonc_2023_1202656 crossref_primary_10_1007_s11805_007_0384_1 crossref_primary_10_1016_j_phrs_2021_105609 crossref_primary_10_1186_s13578_017_0188_9 crossref_primary_10_1007_s13402_024_00925_x crossref_primary_10_1016_j_neo_2018_06_001 crossref_primary_10_1158_1055_9965_EPI_07_2808 crossref_primary_10_1074_jbc_M114_593392 crossref_primary_10_1245_s10434_013_3106_3 crossref_primary_10_3390_cells9061419 crossref_primary_10_1210_en_2012_2164 crossref_primary_10_2353_ajpath_2010_090526 crossref_primary_10_1016_j_lfs_2008_06_019 crossref_primary_10_1016_j_jprot_2014_08_007 crossref_primary_10_1038_nrurol_2010_45 crossref_primary_10_3390_biom12101366 crossref_primary_10_18632_oncotarget_3653 crossref_primary_10_1016_j_ijom_2015_05_009 crossref_primary_10_15406_ogij_2017_06_00210 crossref_primary_10_3390_ijms19082152 crossref_primary_10_3892_ol_2017_6398 crossref_primary_10_1080_15384101_2015_1010893 crossref_primary_10_3892_ol_2017_6034 crossref_primary_10_1007_s10555_012_9377_5 crossref_primary_10_3390_ijms22020628 crossref_primary_10_1016_j_yexmp_2018_01_005 crossref_primary_10_1158_0008_5472_CAN_08_2067 crossref_primary_10_1371_journal_pone_0143659 crossref_primary_10_3748_wjg_v21_i1_196 crossref_primary_10_1038_onc_2013_187 crossref_primary_10_18632_oncotarget_26103 crossref_primary_10_1016_j_jcpa_2010_01_002 crossref_primary_10_1038_onc_2008_418 crossref_primary_10_1158_0008_5472_CAN_13_0755 crossref_primary_10_3892_mmr_2019_10293 crossref_primary_10_1292_jvms_001681 crossref_primary_10_1002_pros_21213 crossref_primary_10_1038_s41467_019_10269_y crossref_primary_10_1186_1471_2407_10_94 crossref_primary_10_1038_bjc_2011_262 crossref_primary_10_1002_path_2859 crossref_primary_10_4236_ojbiphy_2018_82005 crossref_primary_10_1016_j_bbapap_2009_05_001 crossref_primary_10_1158_0008_5472_CAN_09_4041 crossref_primary_10_3390_cancers13122980 crossref_primary_10_1016_j_gene_2016_11_034 crossref_primary_10_1089_scd_2014_0225 crossref_primary_10_1371_journal_pone_0165776 crossref_primary_10_1210_en_2011_1121 crossref_primary_10_1007_s00345_012_1013_z crossref_primary_10_1038_modpathol_2011_167 crossref_primary_10_1111_j_1476_5829_2011_00313_x crossref_primary_10_1091_mbc_e12_04_0276 crossref_primary_10_3109_07357907_2010_512595 crossref_primary_10_1038_modpathol_2011_59 crossref_primary_10_3892_etm_2018_5688 crossref_primary_10_1158_0008_5472_CAN_08_4312 crossref_primary_10_1111_jcmm_12482 crossref_primary_10_1002_ptr_6087 crossref_primary_10_3892_or_2014_3090 crossref_primary_10_1016_j_humpath_2012_03_018 crossref_primary_10_1016_j_gene_2020_144899 crossref_primary_10_1111_j_1460_9568_2010_07523_x crossref_primary_10_1016_j_febslet_2008_04_032 crossref_primary_10_1186_1471_2407_9_235 crossref_primary_10_1186_s12885_016_2237_x crossref_primary_10_3390_cancers11060784 crossref_primary_10_1158_1541_7786_MCR_10_0081 crossref_primary_10_1186_s13046_019_1248_2 crossref_primary_10_3390_ijms23147844 crossref_primary_10_4137_CPath_S19615 crossref_primary_10_1016_j_prp_2018_07_014 crossref_primary_10_12688_f1000research_2_9_v2 crossref_primary_10_12688_f1000research_2_9_v1 crossref_primary_10_1371_journal_pone_0239088 crossref_primary_10_1002_pros_21086 crossref_primary_10_1002_path_3956 crossref_primary_10_1007_s10585_011_9419_3 crossref_primary_10_1038_onc_2010_377 crossref_primary_10_1002_cam4_719 crossref_primary_10_1016_j_ccr_2009_01_023 crossref_primary_10_3390_molecules22040537 crossref_primary_10_1111_j_1349_7006_2008_00914_x crossref_primary_10_1152_ajpcell_00206_2016 crossref_primary_10_1371_journal_pone_0174486 crossref_primary_10_1007_s12094_022_02851_6 crossref_primary_10_1073_pnas_0708037104 crossref_primary_10_1158_0008_5472_CAN_11_3102 crossref_primary_10_3390_ijms17081308 crossref_primary_10_1002_jcb_23150 crossref_primary_10_1186_s12876_021_01705_9 crossref_primary_10_1002_ijc_23819 crossref_primary_10_2353_ajpath_2010_090233 crossref_primary_10_1016_j_biopha_2018_04_100 crossref_primary_10_1038_cdd_2009_98 crossref_primary_10_1038_oncsis_2012_20 crossref_primary_10_4161_cc_10_12_15883 crossref_primary_10_1073_pnas_0801610105 crossref_primary_10_1186_1752_0509_8_29 crossref_primary_10_1002_pros_23154 crossref_primary_10_1007_s10528_022_10278_5 crossref_primary_10_1371_journal_pone_0222999 crossref_primary_10_1186_s12943_016_0579_2 crossref_primary_10_26442_20795696_2024_2_202799 crossref_primary_10_1007_s00441_014_1912_y crossref_primary_10_1038_emboj_2013_236 crossref_primary_10_1093_abbs_gmw127 crossref_primary_10_3389_fcell_2021_696364 crossref_primary_10_1002_jcb_24481 crossref_primary_10_1517_14728222_2012_714774 crossref_primary_10_4062_biomolther_2021_178 crossref_primary_10_1177_1535370218820287 crossref_primary_10_18632_oncotarget_25184 crossref_primary_10_1158_0008_5472_CAN_07_5266 crossref_primary_10_4137_CIN_S38590 crossref_primary_10_3892_ijmm_2014_1707 crossref_primary_10_1016_j_clgc_2014_08_014 crossref_primary_10_1186_1477_7827_11_93 crossref_primary_10_1016_j_bbagen_2012_07_009 crossref_primary_10_1074_jbc_M111_322800 crossref_primary_10_1016_j_matbio_2022_03_009 crossref_primary_10_2119_molmed_2012_00091 crossref_primary_10_3892_ol_2019_10522 crossref_primary_10_1038_s41389_018_0083_1 crossref_primary_10_18632_oncotarget_9438 crossref_primary_10_3390_cancers12092482 crossref_primary_10_1186_bcr3192 crossref_primary_10_1111_jcmm_12237 crossref_primary_10_3390_cancers14071824 crossref_primary_10_1158_1078_0432_CCR_20_3835 crossref_primary_10_1016_j_yexcr_2013_03_015 crossref_primary_10_1038_onc_2011_54 crossref_primary_10_1038_labinvest_2014_138 crossref_primary_10_1038_onc_2011_383 crossref_primary_10_1016_j_fct_2013_10_021 crossref_primary_10_3109_09513590_2016_1163673 crossref_primary_10_3390_bioengineering6030073 crossref_primary_10_1016_j_urolonc_2008_11_005 crossref_primary_10_3233_CBM_170310 crossref_primary_10_1038_emboj_2009_190 crossref_primary_10_1016_j_humpath_2010_07_020 crossref_primary_10_1136_jcp_2009_069500 crossref_primary_10_1186_1471_2407_13_539 crossref_primary_10_1371_journal_pone_0078200 crossref_primary_10_18632_oncotarget_21928 crossref_primary_10_21303_2504_5679_2016_00090 crossref_primary_10_3390_genes15060777 crossref_primary_10_1007_s13402_021_00651_8 crossref_primary_10_1016_j_tiv_2016_09_003 crossref_primary_10_1002_ijc_31225 crossref_primary_10_1038_s41551_017_0077 crossref_primary_10_1038_s41388_020_01450_5 crossref_primary_10_1002_path_3988 crossref_primary_10_1593_neo_09542 crossref_primary_10_1097_MD_0000000000020076 crossref_primary_10_1111_aogs_13179 crossref_primary_10_1016_j_mam_2016_04_008 crossref_primary_10_3390_cancers14163985 crossref_primary_10_1530_ERC_18_0142 crossref_primary_10_1007_s00595_012_0344_0 crossref_primary_10_3892_ol_2017_5788 crossref_primary_10_1007_s10555_014_9493_5 crossref_primary_10_3390_ijms19030904 crossref_primary_10_1073_pnas_1115191108 crossref_primary_10_1007_s13277_015_3354_x crossref_primary_10_1021_acs_jmedchem_3c00586 crossref_primary_10_3389_fonc_2018_00505 crossref_primary_10_1002_pros_21146 crossref_primary_10_1007_s00404_020_05538_x crossref_primary_10_1159_000495417 crossref_primary_10_18632_oncotarget_16375 crossref_primary_10_1586_erm_10_35 crossref_primary_10_1016_j_phymed_2018_07_001 crossref_primary_10_1186_s12935_016_0295_4 crossref_primary_10_3390_ijms231710095 crossref_primary_10_1158_1078_0432_CCR_12_1558 crossref_primary_10_1371_journal_pgen_1002218 crossref_primary_10_3390_genes15060765 crossref_primary_10_1002_pmic_200800303 crossref_primary_10_1007_s12307_008_0001_8 crossref_primary_10_1007_s12307_011_0085_4 crossref_primary_10_3892_or_2015_3754 crossref_primary_10_1074_jbc_M112_408104 crossref_primary_10_3164_jcbn_14_8 crossref_primary_10_1016_j_bbrc_2009_07_050 crossref_primary_10_3390_cancers13081882 crossref_primary_10_1155_2011_598218 crossref_primary_10_1177_0300985818776054 crossref_primary_10_1158_1078_0432_CCR_09_2823 crossref_primary_10_1080_15287394_2019_1688482 crossref_primary_10_3892_mmr_2020_11126 crossref_primary_10_1074_mcp_M110_001131 crossref_primary_10_1111_j_1530_0277_2009_01061_x crossref_primary_10_1038_onc_2010_170 crossref_primary_10_1016_j_gene_2018_08_071 crossref_primary_10_1016_j_jhep_2014_12_035 crossref_primary_10_1111_j_1349_7006_2011_01919_x crossref_primary_10_3390_cells9081755 crossref_primary_10_1042_BST20120026 crossref_primary_10_1074_jbc_M109_005017 crossref_primary_10_3389_fonc_2020_00554 crossref_primary_10_1007_s12253_011_9454_z crossref_primary_10_1007_s12307_012_0099_6 crossref_primary_10_1016_j_cellsig_2017_06_016 crossref_primary_10_1016_j_humpath_2013_04_009 crossref_primary_10_1016_j_biocel_2014_10_028 crossref_primary_10_18632_oncoscience_27 crossref_primary_10_3390_ijms231911378 crossref_primary_10_1371_journal_pgen_1003531 crossref_primary_10_1292_jvms_14_0104 crossref_primary_10_1016_j_bbadis_2016_03_012 crossref_primary_10_1097_SLA_0b013e3182a6909d crossref_primary_10_1155_2010_485468 crossref_primary_10_3390_cancers15071957 crossref_primary_10_1007_s10911_010_9181_1 crossref_primary_10_1002_mc_20448 crossref_primary_10_18632_oncotarget_10733 crossref_primary_10_1016_j_ejso_2016_05_010 crossref_primary_10_1016_j_prp_2015_09_005 crossref_primary_10_1002_pros_23467 crossref_primary_10_1016_j_prp_2023_154839 crossref_primary_10_23868_201906022 crossref_primary_10_1002_mrd_22006 crossref_primary_10_1128_MCB_01153_08 crossref_primary_10_1016_j_aml_2012_06_015 crossref_primary_10_1007_s12079_011_0148_9 crossref_primary_10_1007_s12094_016_1582_1 crossref_primary_10_1016_j_yexmp_2013_10_008 crossref_primary_10_3892_ol_2017_6791 crossref_primary_10_1007_s13402_013_0129_5 crossref_primary_10_1080_09553000802662595 crossref_primary_10_1007_s10585_008_9170_6 crossref_primary_10_1091_mbc_e11_04_0306 crossref_primary_10_1007_s00109_014_1160_3 crossref_primary_10_1016_j_semcdb_2015_02_008 crossref_primary_10_1093_humupd_dmy035 crossref_primary_10_1111_jcmm_14572 crossref_primary_10_1158_1535_7163_MCT_08_0653 crossref_primary_10_1158_1535_7163_MCT_09_0191 crossref_primary_10_2174_1573407219666230529151351 crossref_primary_10_1002_jcp_21694 crossref_primary_10_1074_jbc_M112_424903 crossref_primary_10_1016_j_bbcan_2014_01_002 crossref_primary_10_1517_14728220903460340 crossref_primary_10_1074_mcp_M112_027086 crossref_primary_10_1002_pros_23116 crossref_primary_10_1186_s13000_015_0424_8 crossref_primary_10_1016_j_dld_2010_04_013 crossref_primary_10_1158_1541_7786_MCR_09_0368 crossref_primary_10_1515_BC_2008_076 crossref_primary_10_1158_0008_5472_CAN_08_1444 crossref_primary_10_3892_ol_2019_9967 crossref_primary_10_1186_s12976_016_0035_4 crossref_primary_10_1021_acs_jmedchem_2c00573 crossref_primary_10_3389_fcell_2021_642443 crossref_primary_10_1007_s10585_014_9638_5 crossref_primary_10_1097_MD_0000000000015238 crossref_primary_10_1158_0008_5472_CAN_08_2894 crossref_primary_10_1080_15384101_2022_2073047 crossref_primary_10_3390_cancers30100716 crossref_primary_10_1038_labinvest_2010_187 crossref_primary_10_1038_nprot_2009_152 crossref_primary_10_1186_s12943_022_01653_2 crossref_primary_10_1186_2193_1801_3_417 crossref_primary_10_3390_ijms25137143 crossref_primary_10_3892_or_2013_2552 crossref_primary_10_1007_s10585_017_9853_y crossref_primary_10_1007_s13346_012_0079_x crossref_primary_10_1016_j_cellsig_2012_08_004 crossref_primary_10_1007_s10555_013_9438_4 crossref_primary_10_1007_s13277_015_3355_9 crossref_primary_10_1007_s10620_010_1340_0 crossref_primary_10_1016_j_cellsig_2009_09_024 crossref_primary_10_1007_s10120_021_01155_y crossref_primary_10_1007_s10585_016_9796_8 crossref_primary_10_1096_fj_09_151639 crossref_primary_10_1038_aps_2011_20 crossref_primary_10_1038_nrc2620 crossref_primary_10_1038_onc_2016_381 crossref_primary_10_1016_j_jgeb_2017_10_006 crossref_primary_10_1016_j_tranon_2020_100773 crossref_primary_10_1158_1541_7786_MCR_10_0490 crossref_primary_10_1111_febs_13419 crossref_primary_10_1186_1756_9966_32_97 crossref_primary_10_1007_s00428_021_03201_7 crossref_primary_10_1016_j_genrep_2016_02_005 crossref_primary_10_1038_cddis_2014_304 crossref_primary_10_1002_pros_20946 crossref_primary_10_1016_j_humpath_2013_07_029 crossref_primary_10_1158_0008_5472_CAN_10_4417 crossref_primary_10_3892_ol_2015_4029 crossref_primary_10_1016_j_rvsc_2012_10_016 crossref_primary_10_1007_s10911_015_9333_4 crossref_primary_10_1089_gtmb_2023_0368 crossref_primary_10_3892_mco_2013_220 crossref_primary_10_1007_s00401_013_1101_1 crossref_primary_10_1016_j_mehy_2014_11_006 crossref_primary_10_1038_ncb1974 crossref_primary_10_3892_ol_2014_2433 crossref_primary_10_1038_cr_2009_5 crossref_primary_10_1540_jsmr_55_81 crossref_primary_10_3389_fgene_2023_1145454 crossref_primary_10_1186_bcr2938 crossref_primary_10_1073_pnas_0902368106 crossref_primary_10_1007_s10585_012_9545_6 crossref_primary_10_1016_j_canlet_2012_06_013 crossref_primary_10_3109_00313021003631353 crossref_primary_10_1038_nm0909_1010 crossref_primary_10_1186_1471_2407_14_855 crossref_primary_10_3390_cells10020254 crossref_primary_10_1042_CBI20110151 crossref_primary_10_1016_j_lungcan_2011_11_015 crossref_primary_10_1016_j_jprot_2012_10_016 crossref_primary_10_1074_jbc_M807823200 crossref_primary_10_1007_s10585_021_10075_1 crossref_primary_10_1074_jbc_M112_434225 crossref_primary_10_1002_jcp_26302 crossref_primary_10_18632_oncotarget_23826 crossref_primary_10_2217_imt_10_87 crossref_primary_10_1111_his_13094 crossref_primary_10_3389_fonc_2014_00370 crossref_primary_10_1002_1878_0261_13172 crossref_primary_10_1016_j_jid_2016_11_046 crossref_primary_10_1371_journal_pone_0118906 crossref_primary_10_1016_j_yexcr_2017_02_041 crossref_primary_10_1002_ijc_25500 crossref_primary_10_1016_j_ejca_2008_08_024 crossref_primary_10_3892_ol_2019_10972 crossref_primary_10_1158_1541_7786_MCR_10_0568 crossref_primary_10_1371_journal_pone_0017092 crossref_primary_10_1371_journal_pone_0047587 crossref_primary_10_1016_j_gene_2018_04_040 crossref_primary_10_1155_2012_928127 crossref_primary_10_1016_j_yexcr_2012_07_019 crossref_primary_10_2217_fon_12_3 crossref_primary_10_1016_j_stem_2008_05_007 crossref_primary_10_1186_1471_2407_9_318 crossref_primary_10_3109_01443615_2014_960827 crossref_primary_10_1002_path_2371 crossref_primary_10_5009_gnl18484 crossref_primary_10_1111_his_12057 crossref_primary_10_1371_journal_pone_0013971 crossref_primary_10_1007_s12094_019_02138_3 crossref_primary_10_1016_j_omtn_2019_07_002 crossref_primary_10_1186_s12943_017_0624_9 crossref_primary_10_3390_cancers13102380 crossref_primary_10_1039_C2MB25401H crossref_primary_10_1002_mc_22443 crossref_primary_10_1158_1940_6207_CAPR_10_0306 crossref_primary_10_18632_oncotarget_18277 crossref_primary_10_1126_scisignal_aav2041 crossref_primary_10_1371_journal_pone_0096501 crossref_primary_10_1042_BST20160177 crossref_primary_10_3390_nano8020064 crossref_primary_10_1016_j_niox_2019_04_009 crossref_primary_10_3390_ijms232113645 crossref_primary_10_1002_jcb_28393 crossref_primary_10_1016_j_canlet_2017_08_003 crossref_primary_10_1016_j_cellsig_2013_12_017 crossref_primary_10_1002_hep_28755 crossref_primary_10_1002_stem_101 crossref_primary_10_3892_or_2013_2401 crossref_primary_10_7717_peerj_11342 crossref_primary_10_1007_s10585_020_10033_3 crossref_primary_10_1016_j_gendis_2020_07_009 crossref_primary_10_1007_s12032_014_0951_2 crossref_primary_10_1038_onc_2016_227 crossref_primary_10_1002_gcc_22270 crossref_primary_10_1111_1440_1681_12899 crossref_primary_10_1016_j_canlet_2010_01_013 crossref_primary_10_1038_ncb1762 crossref_primary_10_18632_oncotarget_20219 crossref_primary_10_1038_ncb2976 crossref_primary_10_1111_j_1365_2559_2012_04195_x crossref_primary_10_1088_1478_3975_9_1_016001 crossref_primary_10_1093_carcin_bgt276 crossref_primary_10_1007_s00418_009_0595_z crossref_primary_10_3892_ijo_2014_2813 crossref_primary_10_1016_j_bbrc_2017_03_029 crossref_primary_10_1016_j_canlet_2013_06_003 crossref_primary_10_1016_j_cellsig_2013_12_005 crossref_primary_10_1155_2011_591427 crossref_primary_10_1158_1535_7163_MCT_12_0100 crossref_primary_10_1186_s13058_020_01366_8 crossref_primary_10_1111_j_1349_7006_2009_01357_x crossref_primary_10_1007_s12328_018_0859_z crossref_primary_10_1111_pin_12213 crossref_primary_10_1007_s10585_010_9341_0 crossref_primary_10_1080_10717544_2017_1417511 crossref_primary_10_18632_oncotarget_24971 crossref_primary_10_3390_pathophysiology29020017 crossref_primary_10_1038_onc_2009_79 crossref_primary_10_1016_j_ajpath_2012_02_020 crossref_primary_10_1186_s12885_015_1124_1 crossref_primary_10_1002_cmdc_202000752 crossref_primary_10_1016_j_ijpharm_2017_09_013 crossref_primary_10_1177_0300985813490757 crossref_primary_10_1016_j_ygyno_2011_02_020 crossref_primary_10_1186_1477_7819_6_60 crossref_primary_10_1016_j_celrep_2019_10_004 crossref_primary_10_1007_s10585_013_9600_y crossref_primary_10_3390_jcm8081253 crossref_primary_10_1172_JCI40555 crossref_primary_10_1002_tox_22420 crossref_primary_10_1016_j_biotechadv_2013_08_016 crossref_primary_10_1111_pin_12685 crossref_primary_10_1158_0008_5472_CAN_13_0085 crossref_primary_10_1186_1471_2407_10_273 crossref_primary_10_1016_j_ejca_2012_02_062 crossref_primary_10_1016_j_critrevonc_2012_05_002 crossref_primary_10_1210_en_2010_0486 crossref_primary_10_3892_or_2014_3163 crossref_primary_10_1016_j_urolonc_2011_12_003 crossref_primary_10_1080_02772248_2015_1137099 crossref_primary_10_1016_j_rvsc_2016_03_020 crossref_primary_10_1007_s11033_020_06078_y crossref_primary_10_1007_s10555_013_9483_z crossref_primary_10_1111_j_1751_1097_2012_01093_x crossref_primary_10_1155_2014_415721 crossref_primary_10_3892_or_2016_5095 crossref_primary_10_1111_j_1365_2559_2012_04326_x crossref_primary_10_1002_cam4_68 crossref_primary_10_1002_ijc_28925 crossref_primary_10_1111_j_1365_2559_2010_03588_x crossref_primary_10_1186_s13053_022_00210_8 crossref_primary_10_1371_journal_pone_0134111 crossref_primary_10_1111_j_1440_1843_2012_02173_x crossref_primary_10_1158_1535_7163_MCT_10_0544 crossref_primary_10_1007_s11033_017_4118_z crossref_primary_10_1007_s00428_018_2444_8 crossref_primary_10_1038_onc_2013_215 crossref_primary_10_1097_MD_0000000000005150 crossref_primary_10_1016_j_tcb_2020_07_003 crossref_primary_10_1007_s11033_021_06919_4 crossref_primary_10_3389_fmolb_2020_00071 crossref_primary_10_3390_nu8090581 crossref_primary_10_1517_14728222_2011_645808 crossref_primary_10_1371_journal_pone_0039766 crossref_primary_10_6000_1929_6029_2012_01_02_09 crossref_primary_10_1016_j_yexmp_2017_05_005 crossref_primary_10_3390_ijms19020450 crossref_primary_10_1038_nrc3319 crossref_primary_10_4161_cam_4_1_10313 crossref_primary_10_1002_ijc_25788 crossref_primary_10_3892_ijo_2015_3142 crossref_primary_10_1158_0008_5472_CAN_12_1223 crossref_primary_10_1016_j_biomaterials_2023_122180 crossref_primary_10_1016_j_humpath_2013_01_005 crossref_primary_10_5320_wjr_v3_i3_48 crossref_primary_10_1155_2008_762398 crossref_primary_10_3390_cells8111387 crossref_primary_10_1007_s12668_024_01340_0 crossref_primary_10_1016_j_biopha_2023_114770 crossref_primary_10_1089_ars_2021_0199 crossref_primary_10_18632_oncotarget_12639 crossref_primary_10_1007_s13277_013_0662_x crossref_primary_10_1093_carcin_bgac054 crossref_primary_10_1002_jso_23020 crossref_primary_10_1007_s10911_010_9177_x crossref_primary_10_18632_oncotarget_11314 crossref_primary_10_1128_MCB_00299_12 crossref_primary_10_18632_oncotarget_13615 crossref_primary_10_1007_s10517_016_3559_z crossref_primary_10_1140_epjp_s13360_024_05188_x crossref_primary_10_1007_s00432_011_1023_z crossref_primary_10_1016_j_canlet_2014_08_015 crossref_primary_10_1007_s10585_012_9537_6 crossref_primary_10_1371_journal_pone_0023833 crossref_primary_10_1016_j_canlet_2020_05_012 crossref_primary_10_1007_s13402_019_00442_2 crossref_primary_10_1007_BF03346466 crossref_primary_10_1098_rsob_150032 crossref_primary_10_1016_j_hoc_2008_08_007 crossref_primary_10_1155_2013_159786 crossref_primary_10_1590_1678_4162_12324 crossref_primary_10_1111_j_1440_1827_2008_02339_x crossref_primary_10_1016_j_ejcb_2014_03_002 crossref_primary_10_1016_j_tranon_2021_101036 crossref_primary_10_1186_1471_2407_11_130 crossref_primary_10_3390_nu9070728 crossref_primary_10_1016_j_adcanc_2022_100062 crossref_primary_10_1186_s12967_014_0244_8 crossref_primary_10_1016_j_tranon_2022_101435 crossref_primary_10_1007_s00428_014_1628_0 crossref_primary_10_1007_s10735_015_9614_7 crossref_primary_10_1074_jbc_M114_556126 crossref_primary_10_1158_1078_0432_CCR_19_0908 crossref_primary_10_1016_j_humpath_2016_06_020 crossref_primary_10_1016_j_bbrc_2011_07_074 crossref_primary_10_1007_s12282_013_0487_x crossref_primary_10_1248_bpb_b23_00631 crossref_primary_10_18632_oncotarget_10017 crossref_primary_10_1016_j_yexcr_2019_111671 crossref_primary_10_1039_C4IB00022F crossref_primary_10_1073_pnas_1301021110 crossref_primary_10_1007_s12253_013_9690_5 crossref_primary_10_1016_j_bbamem_2014_08_016 crossref_primary_10_7554_eLife_10734 crossref_primary_10_1038_onc_2008_340 crossref_primary_10_1080_07357907_2017_1378671 crossref_primary_10_3892_mco_2012_28 crossref_primary_10_1016_j_anndiagpath_2015_10_011 crossref_primary_10_1186_1479_5876_11_164 crossref_primary_10_1080_15384101_2017_1308617 crossref_primary_10_1007_s00428_019_02532_w crossref_primary_10_1146_annurev_pathol_020117_043854 crossref_primary_10_1002_cam4_1520 crossref_primary_10_1007_s00432_014_1840_y crossref_primary_10_3892_or_2016_4766 crossref_primary_10_1007_s00418_008_0464_1 crossref_primary_10_1021_pr8010974 crossref_primary_10_1586_14737140_2014_953935 crossref_primary_10_3934_genet_2015_1_97 crossref_primary_10_1089_cbr_2011_1122 crossref_primary_10_1016_j_molmed_2011_11_003 crossref_primary_10_1002_pmic_200900819 crossref_primary_10_1007_s00441_014_2001_y crossref_primary_10_3892_ijo_2013_1825 crossref_primary_10_1016_j_jsbmb_2016_02_005 crossref_primary_10_4048_jbc_2015_18_4_303 crossref_primary_10_1186_bcr3623 crossref_primary_10_1002_mc_23247 crossref_primary_10_1007_s12307_010_0058_z crossref_primary_10_1007_s13277_011_0176_3 crossref_primary_10_3390_cells7100167 crossref_primary_10_3892_mmr_2018_9091 crossref_primary_10_1016_j_bbcan_2018_10_004 crossref_primary_10_1038_s41598_022_11023_z crossref_primary_10_1155_2014_986768 crossref_primary_10_1016_j_bbadis_2015_06_009 crossref_primary_10_1038_onc_2009_399 crossref_primary_10_1634_stemcells_2007_1076 crossref_primary_10_1007_s11255_014_0874_z crossref_primary_10_1007_s00262_008_0473_x crossref_primary_10_1007_s13402_017_0328_6 crossref_primary_10_1089_adt_2014_593 crossref_primary_10_1002_cbin_10963 crossref_primary_10_1016_j_bbrc_2018_06_144 crossref_primary_10_1002_cam4_109 crossref_primary_10_1038_onc_2010_608 crossref_primary_10_3390_jcm2040264 crossref_primary_10_1016_j_biocel_2008_07_019 crossref_primary_10_1091_mbc_e14_03_0825 crossref_primary_10_3390_cancers9100131 crossref_primary_10_1016_j_canlet_2016_02_053 crossref_primary_10_1038_ncb1207_1341 crossref_primary_10_1016_j_ccr_2012_09_022 crossref_primary_10_1093_carcin_bgp048 crossref_primary_10_1186_bcr2887 crossref_primary_10_18632_oncotarget_14511 crossref_primary_10_3892_ol_2016_5270 crossref_primary_10_1002_jcb_24506 crossref_primary_10_5487_TR_2008_24_1_001 crossref_primary_10_1016_j_bbadis_2019_04_002 crossref_primary_10_3892_ijmm_2019_4107 crossref_primary_10_1177_0300985818785680 crossref_primary_10_1007_s10529_015_1925_y crossref_primary_10_1039_C6TB02008A crossref_primary_10_3390_ijms23169319 crossref_primary_10_1016_j_tem_2011_12_001 crossref_primary_10_1007_s10585_010_9357_5 crossref_primary_10_3892_or_2013_2801 crossref_primary_10_1007_s10549_012_1969_9 crossref_primary_10_1038_nrd2372 crossref_primary_10_1016_j_jcpa_2015_08_006 crossref_primary_10_1158_0008_5472_CAN_14_2535 crossref_primary_10_1186_s12964_021_00726_x crossref_primary_10_1080_01635581_2013_785002 crossref_primary_10_3390_ijms23126559 crossref_primary_10_1242_jcs_019315 crossref_primary_10_1016_j_gie_2009_11_036 crossref_primary_10_1038_embor_2008_74 crossref_primary_10_15430_JCP_2020_25_3_152 crossref_primary_10_1042_BCJ20160782 crossref_primary_10_1186_s12967_015_0551_8 crossref_primary_10_1007_s00432_019_02852_z crossref_primary_10_1016_j_ijpharm_2017_09_066 crossref_primary_10_1038_s41388_024_03055_8 crossref_primary_10_1111_j_1755_148X_2011_00931_x crossref_primary_10_1007_s11523_016_0463_4 crossref_primary_10_1158_0008_5472_CAN_08_1942 crossref_primary_10_3390_cells11121858 crossref_primary_10_3892_ol_2016_5369 crossref_primary_10_1016_j_biopha_2012_06_002 crossref_primary_10_1186_scrt433 crossref_primary_10_1002_emmm_201000095 crossref_primary_10_1002_ijc_24036 crossref_primary_10_3390_cancers2042058 crossref_primary_10_3892_ijo_2014_2413 crossref_primary_10_1111_bph_12260 crossref_primary_10_3892_ijmm_2013_1538 crossref_primary_10_5794_jjoms_56_441 crossref_primary_10_1007_s10585_008_9167_1 crossref_primary_10_2217_fon_09_93 crossref_primary_10_1111_j_1478_3231_2008_01707_x crossref_primary_10_1016_j_canlet_2012_03_035 crossref_primary_10_1038_bjc_2011_34 crossref_primary_10_1111_j_1365_2559_2009_03327_x crossref_primary_10_1089_scd_2012_0435 crossref_primary_10_18632_oncotarget_7734 crossref_primary_10_3892_ijo_2015_3144 crossref_primary_10_1186_1756_0500_5_343 crossref_primary_10_4049_jimmunol_1601705 crossref_primary_10_1155_2020_8886955 crossref_primary_10_1158_0008_5472_CAN_11_2905 crossref_primary_10_1016_j_ctrv_2023_102557 crossref_primary_10_1158_1940_6207_PREV_08_CN12_03 crossref_primary_10_4161_cc_22225 crossref_primary_10_1007_s00403_012_1260_2 crossref_primary_10_1016_j_arcmed_2010_04_010 crossref_primary_10_1186_s40880_016_0162_7 crossref_primary_10_3892_ol_2015_3880 crossref_primary_10_1007_s00441_013_1566_1 crossref_primary_10_1016_j_heliyon_2024_e30833 crossref_primary_10_3727_096504016X14570992647203 crossref_primary_10_1007_s10911_008_9097_1 crossref_primary_10_3390_cancers2021236 crossref_primary_10_1158_0008_5472_CAN_09_4613 crossref_primary_10_18632_oncotarget_14767 crossref_primary_10_3389_fgene_2022_905047 crossref_primary_10_1016_j_bbrc_2015_01_114 crossref_primary_10_3389_fonc_2022_903016 crossref_primary_10_1007_s12079_018_0451_9 crossref_primary_10_1038_ncomms11123 crossref_primary_10_1158_0008_5472_CAN_09_2670 |
| Cites_doi | 10.1677/erc.1.00958 10.1002/pros.20488 10.1016/S0012-1606(98)80005-5 10.1016/j.cell.2004.06.006 10.1158/1078-0432.CCR-06-0478 10.1158/0008-5472.CAN-05-0289 10.1016/j.juro.2006.06.014 10.1242/dev.00531 10.1177/10454411950060030301 10.1002/pros.20085 10.2741/2075 10.1016/S0074-7696(08)60834-7 10.1038/sj.onc.1209254 10.1097/01.LAB.0000059927.97515.FD 10.1002/ijc.2910630612 10.1158/0008-5472.CAN-05-0616 10.1158/0008-5472.CAN-04-3785 10.1007/s10585-005-5141-3 10.1242/jcs.00224 10.1038/nature02962 10.1056/NEJM198612253152606 10.1242/jcs.112.24.4615 10.1002/pros.20469 10.1007/s10585-004-4117-z 10.1158/1078-0432.CCR-05-0632 10.1038/35000034 10.1172/JCI200320530 10.1016/S1535-6108(03)00304-0 10.1038/nrm1835 10.1158/0008-5472.CAN-05-3401 10.1172/JCI0215518 10.1016/0012-1606(87)90237-5 10.1016/j.humpath.2005.02.002 10.1016/S0959-437X(02)00320-9 10.1038/sj.bjc.6603700 10.1290/1543-706X(2003)039<0428:EMIFOO>2.0.CO;2 10.1038/nature03096 10.1002/ijc.22219 10.1002/pros.20334 10.1158/0008-5472.CAN-05-3697 10.1016/S0344-0338(98)80129-5 10.1002/path.1797 10.1515/BC.2006.089 10.2353/ajpath.2007.060696 10.1089/scd.1.1994.3.315 10.1002/cm.20095 10.1083/jcb.147.3.631 10.1016/j.ccr.2006.10.008 10.1097/01.pas.0000213413.33558.85 10.1016/S0959-8049(01)00143-5 10.1023/B:JOMG.0000037161.91969.de 10.1074/jbc.M103167200 10.1016/j.acthis.2006.05.009 10.1158/0008-5472.CAN-05-0699 10.1023/B:BREA.0000014042.54925.cc 10.1002/(SICI)1096-9896(199610)180:2<175::AID-PATH630>3.0.CO;2-G 10.1158/0008-5472.CAN-06-2044 10.1159/000101298 10.1159/000101311 10.1038/sj.onc.1209519 10.1006/cbir.1995.1090 10.1083/jcb.148.4.779 10.1016/S1040-8428(01)00171-8 10.1007/BF00666165 10.1073/pnas.90.3.999 10.1007/BF01753886 10.1002/jcb.20032 10.1242/dev.125.16.3111 10.1016/0092-8674(95)90276-7 10.1006/excr.2000.5106 10.1002/jcp.1041500314 10.1038/sj.onc.1210026 10.1111/j.1365-2559.1978.tb01698.x 10.1016/S0002-9440(10)61166-2 10.1016/j.ccr.2005.07.009 10.1126/science.1094291 10.1007/s10585-004-3759-1 10.1093/ndt/17.suppl_9.65 10.1016/S0070-2153(08)60760-7 10.1159/000147748 10.1007/s00428-005-0118-9 10.1073/pnas.96.11.6249 10.1016/j.ceb.2007.02.007 10.1038/sj.onc.1209265 10.1073/pnas.012425299 10.1158/0008-5472.CAN-06-0410 10.1159/000084508 10.1016/j.cell.2004.07.011 10.1158/0008-5472.CAN-06-3689 10.1159/000147752 10.1073/pnas.91.12.5657 10.1159/000147847 10.1038/415530a 10.5858/2007-131-205-EAENOB 10.1242/jcs.003129 10.1186/bcr1656 10.1073/pnas.0603090103 |
| ContentType | Journal Article |
| Copyright | Copyright © 2007 Wiley‐Liss, Inc. |
| Copyright_xml | – notice: Copyright © 2007 Wiley‐Liss, Inc. |
| DBID | BSCLL CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
| DOI | 10.1002/jcp.21223 |
| DatabaseName | Istex Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology Biology |
| EISSN | 1097-4652 |
| EndPage | 383 |
| ExternalDocumentID | 10_1002_jcp_21223 17680632 JCP21223 ark_67375_WNG_LJSVKFTT_Q |
| Genre | reviewArticle Research Support, U.S. Gov't, Non-P.H.S Review Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: Victorian Breast Cancer Research Consortium – fundername: Department of Defence Congressionally Directed Medical Research Program funderid: DAMD17‐03‐1‐0416 |
| GroupedDBID | --- -DZ -~X .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 31~ 33P 36B 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 85S 8UM 930 9M8 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABDPE ABEFU ABEML ABIJN ABJNI ABPPZ ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACNCT ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHMBA AIAGR AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AUFTA AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BQCPF BROTX BRXPI BSCLL BY8 CS3 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRSTM DU5 EBD EBS EJD EMB EMOBN F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.T H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ H~9 IH2 IX1 J0M JPC KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M56 MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MVM MXFUL MXSTM N04 N05 N9A NEJ NF~ NNB O66 O9- OHT OIG P2P P2W P2X P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO ROL RWI RWR RX1 RYL S10 SAMSI SUPJJ SV3 TN5 TWZ UB1 UPT V2E V8K VQP W8V W99 WBKPD WH7 WIB WIH WIK WJL WNSPC WOHZO WQJ WRC WXSBR WYB WYISQ X7M XG1 XJT XOL XPP XSW XV2 Y6R YQT YZZ ZGI ZXP ZZTAW ~IA ~WT AETEA G8K CGR CUY CVF ECM EIF NPM AAMNL AAYXX ACRPL CITATION 7X8 |
| ID | FETCH-LOGICAL-c4623-7ab7006e5379e7abf04a92317bb3b9998499adb09cb3c7cf8fca8170af96ccb13 |
| IEDL.DBID | DR2 |
| ISSN | 0021-9541 |
| IngestDate | Wed Dec 04 03:22:00 EST 2024 Fri Dec 06 03:04:09 EST 2024 Sat Sep 28 07:44:02 EDT 2024 Sat Aug 24 01:18:03 EDT 2024 Wed Oct 30 09:54:22 EDT 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4623-7ab7006e5379e7abf04a92317bb3b9998499adb09cb3c7cf8fca8170af96ccb13 |
| Notes | ArticleID:JCP21223 ark:/67375/WNG-LJSVKFTT-Q Victorian Breast Cancer Research Consortium Department of Defence Congressionally Directed Medical Research Program - No. DAMD17-03-1-0416 istex:57F3BDACAF0C4846DA9FBF9B719B88DA292A162F ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-2 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jcp.21223 |
| PMID | 17680632 |
| PQID | 68228488 |
| PQPubID | 23479 |
| PageCount | 10 |
| ParticipantIDs | proquest_miscellaneous_68228488 crossref_primary_10_1002_jcp_21223 pubmed_primary_17680632 wiley_primary_10_1002_jcp_21223_JCP21223 istex_primary_ark_67375_WNG_LJSVKFTT_Q |
| PublicationCentury | 2000 |
| PublicationDate | November 2007 |
| PublicationDateYYYYMMDD | 2007-11-01 |
| PublicationDate_xml | – month: 11 year: 2007 text: November 2007 |
| PublicationDecade | 2000 |
| PublicationPlace | Hoboken |
| PublicationPlace_xml | – name: Hoboken – name: United States |
| PublicationTitle | Journal of cellular physiology |
| PublicationTitleAlternate | J. Cell. Physiol |
| PublicationYear | 2007 |
| Publisher | Wiley Subscription Services, Inc., A Wiley Company |
| Publisher_xml | – name: Wiley Subscription Services, Inc., A Wiley Company |
| References | Come C, Arnoux V, Bibeau F, Savagner P. 2004. Roles of the transcription factors snail and slug during mammary morphogenesis and breast carcinoma progression. J Mammary Gland Biol Neoplasia 9: 183-193. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, Garcia De Herreros A. 2000. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 84-89. Alexander NR, Tran NL, Rekapally H, Summers CE, Glackin C, Heimark RL. 2006. N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1. Cancer Res 66: 3365-3369. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG. 2002. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110: 341-350. Yates CC, Shepard CR, Stolz DB, Wells A. 2007. Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. Br J Cancer 96: 1246-1252. Duband JL, Monier F, Delannet M, Newgreen D. 1995. Epithelium-mesenchyme transition during neural crest development. Acta Anat (Basel) 154: 63-78. Auersperg N, Pan J, Grove BD, Peterson T, Fisher J, Maines-Bandiera S, Somasiri A, Roskelley CD. 1999. E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium. Proc Natl Acad Sci USA 96: 6249-6254. Chaffer CL, Dopheide B, McCulloch DR, Lee AB, Moseley JM, Thompson EW, Williams ED. 2005. Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder. Clin Exp Metastasis 22: 115-125. Ackland ML, Newgreen D, Price JT, Fridman M, Waltham M, Arvanitis A, Minichiello J, Thompson EW. 2003a. Epidermal growth factor stimulates epithelio-mesenchymal transition in the stable human breast carcinoma cell line variant PMC42-LA. Lab Invest 83: 435-448. Jiang R, Lan Y, Norton CR, Sundberg JP, Gridley T. 1998. The Slug gene is not essential for mesoderm or neural crest development in mice. Dev Biol 198: 277-285. Lacroix M, Leclercq G. 2004. Relevance of breast cancer cell lines as models for breast tumours: An update. Breast Cancer Res Treat 83: 249-289. Whitehead RH, Bertoncello I, Webber LM, Pedersen JS. 1983a. A new human breast carcinoma cell line (PMC42) with stem cell characteristics. I. Morphologic characterization. J Natl Cancer Inst 70: 649-661. Come C, Magnino F, Bibeau F, De Santa Barbara P, Becker KF, Theillet C, Savagner P. 2006. Snail and slug play distinct roles during breast carcinoma progression. Clin Cancer Res 12: 5395-5402. Ip YT, Gridley T. 2002. Cell movements during gastrulation: Snail dependent and independent pathways. Curr Opin Genet Dev 12: 423-429. Ackland ML, Michalczyk A, Whitehead RH. 2001. PMC42, a novel model for the differentiated human breast. Exp Cell Res 263: 14-22. McAlhany SJ, Ayala GE, Frolov A, Ressler SJ, Wheeler TM, Watson JE, Collins C, Rowley DR. 2004. Decreased stromal expression and increased epithelial expression of WFDC1/ps20 in prostate cancer is associated with reduced recurrence-free survival. Prostate 61: 182-191. de Iongh RU, Wederell E, Lovicu FJ, McAvoy JW. 2005. Transforming growth factor-beta-induced epithelial-mesenchymal transition in the lens: A model for cataract formation. Cells Tissues Organs 179: 43-55. Lappin DW, McMahon R, Murphy M, Brady HR. 2002. Gremlin: An example of the re-emergence of developmental programmes in diabetic nephropathy. Nephrol Dial Transplant 17: 65-67. Rae JM, Ramus SJ, Waltham M, Armes JE, Campbell IG, Clarke R, Barndt RJ, Johnson MD, Thompson EW. 2004. Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties. Clin Exp Metastasis 21: 543-552. Chunthapong J, Seftor EA, Khalkhali-Ellis Z, Seftor REB, Amir S, Lubaroff DM, Heidger PM, Jr, Hendrix MJC. 2004. Dual roles of E-cadherin in prostate cancer invasion. J Cell Biochem 91: 649-661. Christiansen JJ, Rajasekaran AK. 2006. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 66: 8319-8326. Lawrence M, Veveris-Lowe T, Whitbread A, Nicol DL, Clements JA. 2007. Epithelial-mesenchymal transition in prostate cancer and the potential role of kallikrein serine proteases. Cells Tissues Organs 185: 111-115. Kalluri R, Neilson EG. 2003. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112: 1776-1784. Nagaraja GM, Othman M, Fox BP, Alsaber R, Pellegrino CM, Zeng Y, Khanna R, Tamburini P, Swaroop A, Kandpal RP. 2006. Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: Comprehensive profiles by representational difference analysis, microarrays and proteomics. Oncogene 25: 2328-2338. Benahmed F, Gross I, Guenot D, Jehan F, Martin E, Domon-Dell C, Brabletz T, Kedinger M, Freund JN, Duluc I. 2007. The microenvironment controls CDX2 homeobox gene expression in colorectal cancer cells. Am J Pathol 170: 733-744. Rosivatz E, Becker KF, Kremmer E, Schott C, Blechschmidt K, Hofler H, Sarbia M. 2006. Expression and nuclear localization of Snail, an E-cadherin repressor, in adenocarcinomas of the upper gastrointestinal tract. Virchows Arch 448: 277-287. Kahn LB, Uys CJ, Dale J, Rutherfoord S. 1978. Carcinoma of the breast with metaplasia to chondrosarcoma: A light and electron microscopic study. Histopathology 2: 93-106. Klymkowsky MW. 2005. Beta-catenin and its regulatory network. Hum Pathol 36: 225-227. Thompson EW, Paik S, Brunner N, Sommers CL, Zugmaier G, Clarke R, Shima TB, Torri J, Donahue S, Lippman ME., et al. 1992. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 150: 534-544. Gu X, Zerbini LF, Otu HH, Bhasin M, Yang Q, Joseph MG, Grall F, Onatunde T, Correa RG, Libermann TA. 2007. Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells. Cancer Res 67: 4219-4226. Sefton M, Sanchez S, Nieto MA. 1998. Conserved and divergent roles for members of the Snail family of transcription factors in the chick and mouse embryo. Development 125: 3111-3121. Nelson WJ, Nusse R. 2004. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303: 1483-1487. Tarin D, Thompson EW, Newgreen DF. 2005. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 65: 5996-6000. Wells CM, Ahmed T, Masters JR, Jones GE. 2005. Rho family GTPases are activated during HGF-stimulated prostate cancer-cell scattering. Cell Motil Cytoskeleton 62: 180-194. Kokinnos M, Wafai R, Wong M, Newgreen D, Thompson E, Waltham M. 2007. Vimentin and epithelial-to-mesenchymal transition in human breast cancer-observations in vitro and in vivo. Cells Tissues Organs 185: in press Moody SE, Perez D, Pan TC, Sarkisian CJ, Portocarrero CP, Sterner CJ, Notorfrancesco KL, Cardiff RD, Chodosh LA. 2005. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8: 197-209. Derycke L, De Wever O, Stove V, Vanhoecke B, Delanghe J, Depypere H, Bracke M. 2006. Soluble N-cadherin in human biological fluids. Int J Cancer 119: 2895-2900. Summerbell D, Rigby PW. 2000. Transcriptional regulation during somitogenesis. Curr Top Dev Biol 48: 301-318. Jaggi M, Nazemi T, Abrahams NA, Baker JJ, Galich A, Smith LM, Balaji KC. 2006. N-cadherin switching occurs in high Gleason grade prostate cancer. Prostate 66: 193-199. Thompson EW, Torri J, Sabol M, Sommers CL, Byers S, Valverius EM, Martin GR, Lippman ME, Stampfer MR, Dickson RB. 1994. Oncogene-induced basement membrane invasiveness in human mammary epithelial cells. Clin Exp Metastasis 12: 181-194. Desmouliere A. 1995. Factors influencing myofibroblast differentiation during wound healing and fibrosis. Cell Biol Int 19: 471-476. Xue C, Plieth D, Venkov C, Xu C, Neilson EG. 2003. The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res 63: 3386-3394. Pantel K, Felber E, Schlimok G. 1994. Detection and characterization of residual disease in breast cancer. J Hematother 3: 315-322. Thompson EW, Newgreen DF, Tarin D. 2005. Carcinoma invasion and metastasis: A role for epithelial-mesenchymal transition? Cancer Res 65: 5991-5995. Gilles C, Polette M, Zahm J, Tournier J, Volders L, Foidart J, Birembaut P. 1999. Vimentin contributes to human mammary epithelial cell migration. J Cell Sci 112: 4615-4625. Gilles C, Polette M, Piette J, Delvigne AC, Thompson EW, Foidart JM, Birembaut P. 1996. Vimentin expression in cervical carcinomas: Association with invasive and migratory potential. J Pathol 180: 175-180. Ackland ML, Ward J, Ackland CM, Greaves M, Walker M. 2003b. Extracellular matrix induces formation of organoids and changes in cell surface morphology in cultured human breast carcinoma cells PMC42-LA. In Vitro Cell Dev Biol Anim 39: 428-433. Willipinski-Stapelfeldt B, Riethdorf S, Assmann V, Woelfle U, Rau T, Sauter G, Heukeshoven J, Pantel K. 2005. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin Cancer Res 11: 8006-8014. Dudas M, Li WY, Kim J, Yang A, Kaartinen V. 2007. Palatal fusion-where do the midline cells go? A review on cleft palate, a major human birth defect. Acta Histochem 109: 1-14. Lebret SC, Newgreen DF, Waltham MC, Price JT, Thompson EW, Ackland ML. 2006. Myoepithelial molecular markers in human breast carcinoma PMC42-LA cells are induced by extracellular matrix and stromal cells. In Vitro Cell Dev Biol Anim 42: 298-307. Li CM, Guo M, Borczuk A, Powell CA, Wei M, Thaker HM, Friedman R, Klein U, Tycko B. 2002. Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition. Am J Pathol 160: 2181-2190. Saegusa M, Hashimura M, Kuwata T, Hamano M, Wani Y, Okayasu I. 2007. A functional role of Cdx2 in {beta}-catenin signaling during trans 2004; 21 2002; 17 2004; 61 2001; 263 2003; 116 2002; 110 2000; 48 2005; 179 2002; 12 2007; 185 2004; 9 2002; 99 2005; 62 1978; 2 2006; 176 2005; 65 2000; 2 2007; 31 1998; 198 2007; 109 2003; 112 2005; 22 1998; 194 1992; 52 1995; 63 1979; 29 2001; 61 1986; 103 1992; 150 2002; 41 2007; 170 2006; 66 2007; 374 1996; 180 2006; 25 2007; 131 2007; 9 2003; 4 2000; 60 1999; 96 1998; 125 2006; 448 2007; 67 2007; 26 2005; 36 1994; 31 1986; 315 1987; 120 2007; 19 2004; 83 2004; 303 2006; 119 2006; 12 2006; 10 2007; 120 2006; 7 2002; 415 2007 1993; 90 1999; 147 1995; 19 2007; 96 2004; 91 1995; 154 1985; 45 2007; 12 1995; 6 1983b; 71 2003; 130 2004; 431 2001; 276 1984; 73 2003b; 39 2002; 160 1995; 82 2006; 42 2004; 432 2000; 148 2005; 8 1983a; 70 2005; 206 1994; 12 2001; 37 1999; 112 1994; 91 2003a; 83 2004; 118 1994; 3 1996; 156 2003; 63 2004; 117 2006; 387 2005; 11 2005; 12 2006; 103 e_1_2_8_26_1 e_1_2_8_49_1 e_1_2_8_68_1 e_1_2_8_5_1 e_1_2_8_9_1 e_1_2_8_22_1 e_1_2_8_45_1 e_1_2_8_64_1 e_1_2_8_87_1 e_1_2_8_41_1 Lebret SC (e_1_2_8_58_1) 2006; 42 e_1_2_8_60_1 e_1_2_8_83_1 e_1_2_8_19_1 e_1_2_8_109_1 e_1_2_8_15_1 e_1_2_8_38_1 e_1_2_8_57_1 e_1_2_8_91_1 e_1_2_8_95_1 Saegusa M (e_1_2_8_80_1) 2007 e_1_2_8_99_1 e_1_2_8_105_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_53_1 e_1_2_8_76_1 e_1_2_8_101_1 e_1_2_8_30_1 e_1_2_8_72_1 e_1_2_8_25_1 e_1_2_8_48_1 Sommers CL (e_1_2_8_85_1) 1992; 52 e_1_2_8_2_1 Tomita K (e_1_2_8_94_1) 2000; 60 e_1_2_8_110_1 e_1_2_8_6_1 e_1_2_8_21_1 e_1_2_8_67_1 e_1_2_8_44_1 e_1_2_8_86_1 Zajchowski DA (e_1_2_8_111_1) 2001; 61 e_1_2_8_63_1 Gao X (e_1_2_8_29_1) 2007; 374 e_1_2_8_40_1 e_1_2_8_82_1 e_1_2_8_18_1 e_1_2_8_14_1 e_1_2_8_37_1 e_1_2_8_79_1 e_1_2_8_90_1 e_1_2_8_98_1 e_1_2_8_10_1 e_1_2_8_56_1 e_1_2_8_106_1 e_1_2_8_33_1 e_1_2_8_75_1 e_1_2_8_52_1 e_1_2_8_71_1 e_1_2_8_28_1 Monaghan P (e_1_2_8_66_1) 1985; 45 e_1_2_8_24_1 e_1_2_8_47_1 e_1_2_8_3_1 e_1_2_8_81_1 e_1_2_8_7_1 Deyrup AT (e_1_2_8_23_1) 2007; 131 e_1_2_8_20_1 e_1_2_8_43_1 e_1_2_8_89_1 e_1_2_8_62_1 e_1_2_8_17_1 e_1_2_8_13_1 e_1_2_8_36_1 e_1_2_8_59_1 e_1_2_8_70_1 Kokinnos M (e_1_2_8_50_1) 2007; 185 e_1_2_8_97_1 Ishikawa S (e_1_2_8_39_1) 1979; 29 e_1_2_8_32_1 e_1_2_8_55_1 e_1_2_8_78_1 Whitehead RH (e_1_2_8_102_1) 1983; 70 Whitehead RH (e_1_2_8_103_1) 1983; 71 e_1_2_8_51_1 e_1_2_8_74_1 e_1_2_8_93_1 e_1_2_8_46_1 Xue C (e_1_2_8_107_1) 2003; 63 e_1_2_8_27_1 e_1_2_8_69_1 e_1_2_8_4_1 e_1_2_8_8_1 e_1_2_8_42_1 e_1_2_8_88_1 Whitehead RH (e_1_2_8_104_1) 1984; 73 e_1_2_8_65_1 e_1_2_8_84_1 e_1_2_8_61_1 e_1_2_8_35_1 e_1_2_8_16_1 e_1_2_8_92_1 e_1_2_8_96_1 e_1_2_8_100_1 e_1_2_8_31_1 e_1_2_8_77_1 e_1_2_8_12_1 e_1_2_8_54_1 e_1_2_8_108_1 e_1_2_8_73_1 |
| References_xml | – volume: 62 start-page: 180 year: 2005 end-page: 194 article-title: Rho family GTPases are activated during HGF‐stimulated prostate cancer‐cell scattering publication-title: Cell Motil Cytoskeleton – volume: 36 start-page: 225 year: 2005 end-page: 227 article-title: Beta‐catenin and its regulatory network publication-title: Hum Pathol – volume: 21 start-page: 535 year: 2004 end-page: 541 article-title: LCC15‐MB cells are MDA‐MB‐435: A review of misidentified breast and prostate cell lines publication-title: Clin Exp Metastasis – volume: 3 start-page: 315 year: 1994 end-page: 322 article-title: Detection and characterization of residual disease in breast cancer publication-title: J Hematother – volume: 31 start-page: 85 year: 2007 end-page: 94 article-title: Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: Special reference to its inverse relationship with E‐cadherin expression publication-title: Am J Surg Pathol – volume: 82 start-page: 969 year: 1995 end-page: 979 article-title: Dorsal differentiation of neural plate cells induced by BMP‐mediated signals from epidermal ectoderm publication-title: Cell – volume: 67 start-page: 4219 year: 2007 end-page: 4226 article-title: Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells publication-title: Cancer Res – volume: 9 start-page: 183 year: 2004 end-page: 193 article-title: Roles of the transcription factors snail and slug during mammary morphogenesis and breast carcinoma progression publication-title: J Mammary Gland Biol Neoplasia – volume: 66 start-page: 11271 year: 2006 end-page: 11278 article-title: Mesenchymal‐to‐epithelial transition facilitates bladder cancer metastasis: Role of fibroblast growth factor receptor‐2 publication-title: Cancer Res – volume: 52 start-page: 5190 year: 1992 end-page: 5197 article-title: Loss of epithelial markers and acquisition of vimentin expression in adriamycin‐ and vinblastine‐resistant human breast cancer cell lines publication-title: Cancer Res – volume: 7 start-page: 131 year: 2006 end-page: 142 article-title: Complex networks orchestrate epithelial‐mesenchymal transitions publication-title: Nat Rev Mol Cell Biol – volume: 31 start-page: 325 year: 1994 end-page: 335 article-title: Differentiation state and invasiveness of human breast cancer cell lines publication-title: Breast Cancer Res Treat – volume: 109 start-page: 1 year: 2007 end-page: 14 article-title: Palatal fusion—where do the midline cells go? A review on cleft palate, a major human birth defect publication-title: Acta Histochem – volume: 66 start-page: 3365 year: 2006 end-page: 3369 article-title: N‐cadherin gene expression in prostate carcinoma is modulated by integrin‐dependent nuclear translocation of Twist1 publication-title: Cancer Res – volume: 431 start-page: 707 year: 2004 end-page: 712 article-title: Hedgehog signalling in prostate regeneration, neoplasia and metastasis publication-title: Nature – volume: 66 start-page: 6919 year: 2006 end-page: 6927 article-title: SYT‐SSX1 and SYT‐SSX2 interfere with repression of E‐cadherin by snail and slug: A potential mechanism for aberrant mesenchymal to epithelial transition in human synovial sarcoma publication-title: Cancer Res – volume: 41 start-page: 11 year: 2002 end-page: 28 article-title: Cell adhesion molecules and adhesion abnormalities in prostate cancer publication-title: Crit Rev Oncol Hematol – volume: 194 start-page: 701 year: 1998 end-page: 704 article-title: Nuclear overexpression of the oncoprotein beta‐catenin in colorectal cancer is localized predominantly at the invasion front publication-title: Pathol Res Pract – volume: 99 start-page: 365 year: 2002 end-page: 370 article-title: Dysadherin, a cancer‐associated cell membrane glycoprotein, down‐regulates E‐cadherin and promotes metastasis publication-title: Proc Natl Acad Sci USA – volume: 180 start-page: 175 year: 1996 end-page: 180 article-title: Vimentin expression in cervical carcinomas: Association with invasive and migratory potential publication-title: J Pathol – volume: 22 start-page: 115 year: 2005 end-page: 125 article-title: Upregulated MT1‐MMP/TIMP‐2 axis in the TSU‐Pr1‐B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder publication-title: Clin Exp Metastasis – volume: 147 start-page: 631 year: 1999 end-page: 644 article-title: N‐cadherin promotes motility in human breast cancer cells regardless of their E‐cadherin expression publication-title: J Cell Biol – volume: 176 start-page: 1409 year: 2006 end-page: 1414 article-title: E‐cadherin protein expression predicts prostate cancer salvage radiotherapy outcomes publication-title: J Urol – volume: 91 start-page: 649 year: 2004 end-page: 661 article-title: Dual roles of E‐cadherin in prostate cancer invasion publication-title: J Cell Biochem – volume: 12 start-page: 458 year: 2007 end-page: 470 article-title: Wnt/FZD signaling and colorectal cancer morphogenesis publication-title: Front Biosci – volume: 37 start-page: 1475 year: 2001 end-page: 1481 article-title: Abnormal E‐cadherin expression and prostate cell blood dissemination as markers of biological recurrence in cancer publication-title: Eur J Cancer – volume: 117 start-page: 927 year: 2004 end-page: 939 article-title: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis publication-title: Cell – volume: 11 start-page: 8006 year: 2005 end-page: 8014 article-title: Changes in cytoskeletal protein composition indicative of an epithelial‐mesenchymal transition in human micrometastatic and primary breast carcinoma cells publication-title: Clin Cancer Res – volume: 12 start-page: 423 year: 2002 end-page: 429 article-title: Cell movements during gastrulation: Snail dependent and independent pathways publication-title: Curr Opin Genet Dev – volume: 120 start-page: 1646 year: 2007 end-page: 1653 article-title: TGFbeta3 inhibits E‐cadherin gene expression in palate medial‐edge epithelial cells through a Smad2‐Smad4‐LEF1 transcription complex publication-title: J Cell Sci – volume: 116 start-page: 499 year: 2003 end-page: 511 article-title: The transcription factor Slug represses E‐cadherin expression and induces epithelial to mesenchymal transitions: A comparison with Snail and E47 repressors publication-title: J Cell Sci – volume: 9 start-page: R19 year: 2007 article-title: Induction of epithelial to mesenchymal transition in PMC42‐LA human breast carcinoma cells by carcinoma‐associated fibroblast secreted factors publication-title: Breast Cancer Res – volume: 91 start-page: 5657 year: 1994 end-page: 5661 article-title: Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers publication-title: Proc Natl Acad Sci USA – volume: 66 start-page: 1631 year: 2006 end-page: 1640 article-title: Prostate cancer progression into androgen independency is associated with alterations in cell adhesion and invasivity publication-title: Prostate – volume: 61 start-page: 5168 year: 2001 end-page: 5178 article-title: Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells publication-title: Cancer Res – volume: 19 start-page: 150 year: 2007 end-page: 158 article-title: Wnt/beta‐catenin signaling in cancer stemness and malignant behavior publication-title: Curr Opin Cell Biol – volume: 4 start-page: 499 year: 2003 end-page: 515 article-title: Downregulation of caveolin‐1 function by EGF leads to the loss of E‐cadherin, increased transcriptional activity of beta‐catenin, and enhanced tumor cell invasion publication-title: Cancer Cell – volume: 66 start-page: 193 year: 2006 end-page: 199 article-title: N‐cadherin switching occurs in high Gleason grade prostate cancer publication-title: Prostate – volume: 118 start-page: 277 year: 2004 end-page: 279 article-title: Epithelial‐mesenchymal transitions: Twist in development and metastasis publication-title: Cell – volume: 65 start-page: 5769 year: 2005 end-page: 5777 article-title: Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells publication-title: Cancer Res – volume: 170 start-page: 733 year: 2007 end-page: 744 article-title: The microenvironment controls CDX2 homeobox gene expression in colorectal cancer cells publication-title: Am J Pathol – volume: 63 start-page: 815 year: 1995 end-page: 822 article-title: Invasive phenotype of MCF10A cells overexpressing c‐Ha‐ras and c‐erbB‐2 oncogenes publication-title: Int J Cancer – volume: 2 start-page: 84 year: 2000 end-page: 89 article-title: The transcription factor snail is a repressor of E‐cadherin gene expression in epithelial tumour cells publication-title: Nat Cell Biol – volume: 154 start-page: 63 year: 1995 end-page: 78 article-title: Epithelium‐mesenchyme transition during neural crest development publication-title: Acta Anat (Basel) – volume: 415 start-page: 530 year: 2002 end-page: 536 article-title: Gene expression profiling predicts clinical outcome of breast cancer publication-title: Nature – volume: 71 start-page: 1193 year: 1983b end-page: 1203 article-title: A new human breast carcinoma cell line (PMC42) with stem cell characteristics. II. Characterization of cells growing as organoids publication-title: J Natl Cancer Inst – volume: 120 start-page: 348 year: 1987 end-page: 355 article-title: Extracellular matrix from embryonic myocardium elicits an early morphogenetic event in cardiac endothelial differentiation publication-title: Dev Biol – volume: 66 start-page: 8319 year: 2006 end-page: 8326 article-title: Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis publication-title: Cancer Res – volume: 156 start-page: 202 year: 1996 end-page: 216 article-title: Epithelial‐mesenchymal transition during trophoblast differentiation publication-title: Acta Anat (Basel) – volume: 8 start-page: 197 year: 2005 end-page: 209 article-title: The transcriptional repressor Snail promotes mammary tumor recurrence publication-title: Cancer Cell – volume: 103 start-page: 14116 year: 2006 end-page: 14121 article-title: Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticity publication-title: Proc Natl Acad Sci USA – volume: 96 start-page: 1246 year: 2007 end-page: 1252 article-title: Co‐culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E‐cadherin publication-title: Br J Cancer – volume: 448 start-page: 277 year: 2006 end-page: 287 article-title: Expression and nuclear localization of Snail, an E‐cadherin repressor, in adenocarcinomas of the upper gastrointestinal tract publication-title: Virchows Arch – volume: 26 start-page: 2340 year: 2007 end-page: 2352 article-title: Frizzled‐7 dictates three‐dimensional organization of colorectal cancer cell carcinoids publication-title: Oncogene – volume: 25 start-page: 5134 year: 2006 end-page: 5144 article-title: Expression of Snail protein in tumor‐stroma interface publication-title: Oncogene – volume: 110 start-page: 341 year: 2002 end-page: 350 article-title: Evidence that fibroblasts derive from epithelium during tissue fibrosis publication-title: J Clin Invest – volume: 374 start-page: 135 year: 2007 end-page: 146 article-title: Quantum dots for in vivo molecular and cellular imaging publication-title: Methods Mol Biol – volume: 21 start-page: 543 year: 2004 end-page: 552 article-title: Common origins of MDA‐MB‐435 cells from various sources with those shown to have melanoma properties publication-title: Clin Exp Metastasis – volume: 112 start-page: 4615 year: 1999 end-page: 4625 article-title: Vimentin contributes to human mammary epithelial cell migration publication-title: J Cell Sci – volume: 65 start-page: 5153 year: 2005 end-page: 5162 article-title: Up‐regulation of TWIST in prostate cancer and its implication as a therapeutic target publication-title: Cancer Res – volume: 6 start-page: 202 year: 1995 end-page: 217 article-title: Programmed cell death and cell transformation in craniofacial development publication-title: Crit Rev Oral Biol Med – volume: 185 start-page: 111 year: 2007 end-page: 115 article-title: Epithelial‐mesenchymal transition in prostate cancer and the potential role of kallikrein serine proteases publication-title: Cells Tissues Organs – volume: 25 start-page: 2273 year: 2006 end-page: 2284 article-title: Gene expression profiling of breast cell lines identifies potential new basal markers publication-title: Oncogene – volume: 17 start-page: 65 year: 2002 end-page: 67 article-title: Gremlin: An example of the re‐emergence of developmental programmes in diabetic nephropathy publication-title: Nephrol Dial Transplant – volume: 179 start-page: 43 year: 2005 end-page: 55 article-title: Transforming growth factor‐beta‐induced epithelial‐mesenchymal transition in the lens: A model for cataract formation publication-title: Cells Tissues Organs – volume: 198 start-page: 277 year: 1998 end-page: 285 article-title: The Slug gene is not essential for mesoderm or neural crest development in mice publication-title: Dev Biol – volume: 125 start-page: 3111 year: 1998 end-page: 3121 article-title: Conserved and divergent roles for members of the Snail family of transcription factors in the chick and mouse embryo publication-title: Development – volume: 154 start-page: 8 year: 1995 end-page: 20 article-title: An overview of epithelio‐mesenchymal transformation publication-title: Acta Anat (Basel) – volume: 112 start-page: 1776 year: 2003 end-page: 1784 article-title: Epithelial‐mesenchymal transition and its implications for fibrosis publication-title: J Clin Invest – volume: 206 start-page: 451 year: 2005 end-page: 457 article-title: The origin of vimentin expression in invasive breast cancer: Epithelial‐mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential? publication-title: J Pathol – volume: 103 start-page: 89 year: 1986 end-page: 145 article-title: The migration of neural crest cells publication-title: Int Rev Cytol – volume: 160 start-page: 2181 year: 2002 end-page: 2190 article-title: Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal‐epithelial transition publication-title: Am J Pathol – volume: 276 start-page: 30350 year: 2001 end-page: 30358 article-title: Cloning and characterization of three Xenopus slug promoters reveal direct regulation by Lef/beta‐catenin signaling publication-title: J Biol Chem – volume: 73 start-page: 643 year: 1984 end-page: 648 article-title: A new human breast carcinoma cell line (PMC42) with stem cell characteristics. III. Hormone receptor status and responsiveness publication-title: J Natl Cancer Inst – volume: 185 year: 2007 article-title: Vimentin and epithelial‐to‐mesenchymal transition in human breast cancer—observations in vitro and in vivo publication-title: Cells Tissues Organs – volume: 48 start-page: 301 year: 2000 end-page: 318 article-title: Transcriptional regulation during somitogenesis publication-title: Curr Top Dev Biol – volume: 263 start-page: 14 year: 2001 end-page: 22 article-title: PMC42, a novel model for the differentiated human breast publication-title: Exp Cell Res – volume: 83 start-page: 435 year: 2003a end-page: 448 article-title: Epidermal growth factor stimulates epithelio‐mesenchymal transition in the stable human breast carcinoma cell line variant PMC42‐LA publication-title: Lab Invest – volume: 39 start-page: 428 year: 2003b end-page: 433 article-title: Extracellular matrix induces formation of organoids and changes in cell surface morphology in cultured human breast carcinoma cells PMC42‐LA publication-title: In Vitro Cell Dev Biol Anim – volume: 19 start-page: 471 year: 1995 end-page: 476 article-title: Factors influencing myofibroblast differentiation during wound healing and fibrosis publication-title: Cell Biol Int – volume: 148 start-page: 779 year: 2000 end-page: 790 article-title: Exogenous expression of N‐cadherin in breast cancer cells induces cell migration, invasion, and metastasis publication-title: J Cell Biol – volume: 150 start-page: 534 year: 1992 end-page: 544 article-title: Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines publication-title: J Cell Physiol – volume: 29 start-page: 801 year: 1979 end-page: 809 article-title: Ultrastructure of mesodermal mixed tumor of the uterus publication-title: Acta Pathol Jpn – volume: 131 start-page: 205 year: 2007 end-page: 216 article-title: Epithelioid and epithelial neoplasms of bone publication-title: Arch Pathol Lab Med – volume: 42 start-page: 298 year: 2006 end-page: 307 article-title: Myoepithelial molecular markers in human breast carcinoma PMC42‐LA cells are induced by extracellular matrix and stromal cells publication-title: In Vitro Cell Dev Biol Anim – year: 2007 article-title: A functional role of Cdx2 in {beta}‐catenin signaling during trans‐differentiation in endometrial carcinomas publication-title: Carcinogenesis Apr 29 [Epub ahead of print]. – volume: 25 start-page: 2328 year: 2006 end-page: 2338 article-title: Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: Comprehensive profiles by representational difference analysis, microarrays and proteomics publication-title: Oncogene – volume: 66 start-page: 1664 year: 2006 end-page: 1673 article-title: Prostate cancer metastasis: Role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis publication-title: Prostate – volume: 90 start-page: 999 year: 1993 end-page: 1003 article-title: Expression of smooth muscle‐specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue publication-title: Proc Natl Acad Sci USA – volume: 130 start-page: 3111 year: 2003 end-page: 3124 article-title: Neural crest induction by paraxial mesoderm in Xenopus embryos requires FGF signals publication-title: Development – volume: 303 start-page: 1483 year: 2004 end-page: 1487 article-title: Convergence of Wnt, beta‐catenin, and cadherin pathways publication-title: Science – volume: 70 start-page: 649 year: 1983a end-page: 661 article-title: A new human breast carcinoma cell line (PMC42) with stem cell characteristics. I. Morphologic characterization publication-title: J Natl Cancer Inst – volume: 83 start-page: 249 year: 2004 end-page: 289 article-title: Relevance of breast cancer cell lines as models for breast tumours: An update publication-title: Breast Cancer Res Treat – volume: 65 start-page: 5991 year: 2005 end-page: 5995 article-title: Carcinoma invasion and metastasis: A role for epithelial‐mesenchymal transition? publication-title: Cancer Res – volume: 12 start-page: 181 year: 1994 end-page: 194 article-title: Oncogene‐induced basement membrane invasiveness in human mammary epithelial cells publication-title: Clin Exp Metastasis – volume: 10 start-page: 515 year: 2006 end-page: 527 article-title: A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes publication-title: Cancer Cell – volume: 45 start-page: 5088 year: 1985 end-page: 5097 article-title: An immunocytochemical and ultrastructural study of heterogeneity in the human breast carcinoma cell line P MC42 publication-title: Cancer Res – volume: 12 start-page: 5395 year: 2006 end-page: 5402 article-title: Snail and slug play distinct roles during breast carcinoma progression publication-title: Clin Cancer Res – volume: 185 start-page: 7 year: 2007 end-page: 19 article-title: Mesenchymal to epithelial transition in development and disease publication-title: Cells Tissues Organs – volume: 61 start-page: 182 year: 2004 end-page: 191 article-title: Decreased stromal expression and increased epithelial expression of WFDC1/ps20 in prostate cancer is associated with reduced recurrence‐free survival publication-title: Prostate – volume: 119 start-page: 2895 year: 2006 end-page: 2900 article-title: Soluble N‐cadherin in human biological fluids publication-title: Int J Cancer – volume: 60 start-page: 3650 year: 2000 end-page: 3654 article-title: Cadherin switching in human prostate cancer progression publication-title: Cancer Res – volume: 63 start-page: 3386 year: 2003 end-page: 3394 article-title: The gatekeeper effect of epithelial‐mesenchymal transition regulates the frequency of breast cancer metastasis publication-title: Cancer Res – volume: 12 start-page: 631 year: 2005 end-page: 643 article-title: Kallikrein 4 (hK4) and prostate‐specific antigen (PSA) are associated with the loss of E‐cadherin and an epithelial‐mesenchymal transition (EMT)‐like effect in prostate cancer cells publication-title: Endocr Relat Cancer – volume: 432 start-page: 332 year: 2004 end-page: 337 article-title: Stromal fibroblasts in cancer initiation and progression publication-title: Nature – volume: 2 start-page: 93 year: 1978 end-page: 106 article-title: Carcinoma of the breast with metaplasia to chondrosarcoma: A light and electron microscopic study publication-title: Histopathology – volume: 315 start-page: 1650 year: 1986 end-page: 1659 article-title: Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing publication-title: N Engl J Med – volume: 387 start-page: 707 year: 2006 end-page: 714 article-title: The role of kallikrein‐related peptidases in prostate cancer: Potential involvement in an epithelial to mesenchymal transition publication-title: Biol Chem – volume: 96 start-page: 6249 year: 1999 end-page: 6254 article-title: E‐cadherin induces mesenchymal‐to‐epithelial transition in human ovarian surface epithelium publication-title: Proc Natl Acad Sci USA – volume: 65 start-page: 5996 year: 2005 end-page: 6000 article-title: The fallacy of epithelial mesenchymal transition in neoplasia publication-title: Cancer Res – ident: e_1_2_8_97_1 doi: 10.1677/erc.1.00958 – volume: 61 start-page: 5168 year: 2001 ident: e_1_2_8_111_1 article-title: Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells publication-title: Cancer Res contributor: fullname: Zajchowski DA – volume: 73 start-page: 643 year: 1984 ident: e_1_2_8_104_1 article-title: A new human breast carcinoma cell line (PMC42) with stem cell characteristics. III. Hormone receptor status and responsiveness publication-title: J Natl Cancer Inst contributor: fullname: Whitehead RH – volume: 63 start-page: 3386 year: 2003 ident: e_1_2_8_107_1 article-title: The gatekeeper effect of epithelial‐mesenchymal transition regulates the frequency of breast cancer metastasis publication-title: Cancer Res contributor: fullname: Xue C – ident: e_1_2_8_106_1 doi: 10.1002/pros.20488 – ident: e_1_2_8_44_1 doi: 10.1016/S0012-1606(98)80005-5 – ident: e_1_2_8_108_1 doi: 10.1016/j.cell.2004.06.006 – ident: e_1_2_8_19_1 doi: 10.1158/1078-0432.CCR-06-0478 – volume: 60 start-page: 3650 year: 2000 ident: e_1_2_8_94_1 article-title: Cadherin switching in human prostate cancer progression publication-title: Cancer Res contributor: fullname: Tomita K – ident: e_1_2_8_109_1 doi: 10.1158/0008-5472.CAN-05-0289 – ident: e_1_2_8_78_1 doi: 10.1016/j.juro.2006.06.014 – ident: e_1_2_8_67_1 doi: 10.1242/dev.00531 – ident: e_1_2_8_84_1 doi: 10.1177/10454411950060030301 – ident: e_1_2_8_65_1 doi: 10.1002/pros.20085 – ident: e_1_2_8_36_1 doi: 10.2741/2075 – ident: e_1_2_8_73_1 doi: 10.1016/S0074-7696(08)60834-7 – volume: 52 start-page: 5190 year: 1992 ident: e_1_2_8_85_1 article-title: Loss of epithelial markers and acquisition of vimentin expression in adriamycin‐ and vinblastine‐resistant human breast cancer cell lines publication-title: Cancer Res contributor: fullname: Sommers CL – ident: e_1_2_8_15_1 doi: 10.1038/sj.onc.1209254 – year: 2007 ident: e_1_2_8_80_1 article-title: A functional role of Cdx2 in {beta}‐catenin signaling during trans‐differentiation in endometrial carcinomas publication-title: Carcinogenesis Apr 29 [Epub ahead of print]. contributor: fullname: Saegusa M – volume: 42 start-page: 298 year: 2006 ident: e_1_2_8_58_1 article-title: Myoepithelial molecular markers in human breast carcinoma PMC42‐LA cells are induced by extracellular matrix and stromal cells publication-title: In Vitro Cell Dev Biol Anim contributor: fullname: Lebret SC – ident: e_1_2_8_3_1 doi: 10.1097/01.LAB.0000059927.97515.FD – ident: e_1_2_8_32_1 doi: 10.1002/ijc.2910630612 – ident: e_1_2_8_93_1 doi: 10.1158/0008-5472.CAN-05-0616 – ident: e_1_2_8_53_1 doi: 10.1158/0008-5472.CAN-04-3785 – ident: e_1_2_8_12_1 doi: 10.1007/s10585-005-5141-3 – ident: e_1_2_8_10_1 doi: 10.1242/jcs.00224 – ident: e_1_2_8_48_1 doi: 10.1038/nature02962 – ident: e_1_2_8_26_1 doi: 10.1056/NEJM198612253152606 – ident: e_1_2_8_31_1 doi: 10.1242/jcs.112.24.4615 – ident: e_1_2_8_43_1 doi: 10.1002/pros.20469 – ident: e_1_2_8_92_1 doi: 10.1007/s10585-004-4117-z – ident: e_1_2_8_105_1 doi: 10.1158/1078-0432.CCR-05-0632 – ident: e_1_2_8_7_1 doi: 10.1038/35000034 – ident: e_1_2_8_46_1 doi: 10.1172/JCI200320530 – ident: e_1_2_8_63_1 doi: 10.1016/S1535-6108(03)00304-0 – volume: 71 start-page: 1193 year: 1983 ident: e_1_2_8_103_1 article-title: A new human breast carcinoma cell line (PMC42) with stem cell characteristics. II. Characterization of cells growing as organoids publication-title: J Natl Cancer Inst contributor: fullname: Whitehead RH – ident: e_1_2_8_89_1 doi: 10.1038/nrm1835 – ident: e_1_2_8_5_1 doi: 10.1158/0008-5472.CAN-05-3401 – ident: e_1_2_8_40_1 doi: 10.1172/JCI0215518 – ident: e_1_2_8_52_1 doi: 10.1016/0012-1606(87)90237-5 – ident: e_1_2_8_49_1 doi: 10.1016/j.humpath.2005.02.002 – ident: e_1_2_8_38_1 doi: 10.1016/S0959-437X(02)00320-9 – ident: e_1_2_8_110_1 doi: 10.1038/sj.bjc.6603700 – ident: e_1_2_8_4_1 doi: 10.1290/1543-706X(2003)039<0428:EMIFOO>2.0.CO;2 – ident: e_1_2_8_9_1 doi: 10.1038/nature03096 – ident: e_1_2_8_21_1 doi: 10.1002/ijc.22219 – ident: e_1_2_8_42_1 doi: 10.1002/pros.20334 – ident: e_1_2_8_81_1 doi: 10.1158/0008-5472.CAN-05-3697 – ident: e_1_2_8_11_1 doi: 10.1016/S0344-0338(98)80129-5 – volume: 185 year: 2007 ident: e_1_2_8_50_1 article-title: Vimentin and epithelial‐to‐mesenchymal transition in human breast cancer—observations in vitro and in vivo publication-title: Cells Tissues Organs contributor: fullname: Kokinnos M – ident: e_1_2_8_51_1 doi: 10.1002/path.1797 – ident: e_1_2_8_101_1 doi: 10.1515/BC.2006.089 – ident: e_1_2_8_8_1 doi: 10.2353/ajpath.2007.060696 – ident: e_1_2_8_76_1 doi: 10.1089/scd.1.1994.3.315 – ident: e_1_2_8_100_1 doi: 10.1002/cm.20095 – ident: e_1_2_8_74_1 doi: 10.1083/jcb.147.3.631 – volume: 374 start-page: 135 year: 2007 ident: e_1_2_8_29_1 article-title: Quantum dots for in vivo molecular and cellular imaging publication-title: Methods Mol Biol contributor: fullname: Gao X – ident: e_1_2_8_72_1 doi: 10.1016/j.ccr.2006.10.008 – ident: e_1_2_8_41_1 doi: 10.1097/01.pas.0000213413.33558.85 – ident: e_1_2_8_62_1 doi: 10.1016/S0959-8049(01)00143-5 – ident: e_1_2_8_18_1 doi: 10.1023/B:JOMG.0000037161.91969.de – ident: e_1_2_8_95_1 doi: 10.1074/jbc.M103167200 – ident: e_1_2_8_25_1 doi: 10.1016/j.acthis.2006.05.009 – ident: e_1_2_8_88_1 doi: 10.1158/0008-5472.CAN-05-0699 – ident: e_1_2_8_54_1 doi: 10.1023/B:BREA.0000014042.54925.cc – ident: e_1_2_8_30_1 doi: 10.1002/(SICI)1096-9896(199610)180:2<175::AID-PATH630>3.0.CO;2-G – ident: e_1_2_8_13_1 doi: 10.1158/0008-5472.CAN-06-2044 – ident: e_1_2_8_14_1 doi: 10.1159/000101298 – ident: e_1_2_8_56_1 doi: 10.1159/000101311 – ident: e_1_2_8_28_1 doi: 10.1038/sj.onc.1209519 – ident: e_1_2_8_22_1 doi: 10.1006/cbir.1995.1090 – ident: e_1_2_8_35_1 doi: 10.1083/jcb.148.4.779 – ident: e_1_2_8_64_1 doi: 10.1016/S1040-8428(01)00171-8 – volume: 29 start-page: 801 year: 1979 ident: e_1_2_8_39_1 article-title: Ultrastructure of mesodermal mixed tumor of the uterus publication-title: Acta Pathol Jpn contributor: fullname: Ishikawa S – ident: e_1_2_8_86_1 doi: 10.1007/BF00666165 – ident: e_1_2_8_57_1 doi: 10.1073/pnas.90.3.999 – ident: e_1_2_8_91_1 doi: 10.1007/BF01753886 – ident: e_1_2_8_17_1 doi: 10.1002/jcb.20032 – ident: e_1_2_8_83_1 doi: 10.1242/dev.125.16.3111 – ident: e_1_2_8_61_1 doi: 10.1016/0092-8674(95)90276-7 – ident: e_1_2_8_2_1 doi: 10.1006/excr.2000.5106 – ident: e_1_2_8_90_1 doi: 10.1002/jcp.1041500314 – volume: 70 start-page: 649 year: 1983 ident: e_1_2_8_102_1 article-title: A new human breast carcinoma cell line (PMC42) with stem cell characteristics. I. Morphologic characterization publication-title: J Natl Cancer Inst contributor: fullname: Whitehead RH – ident: e_1_2_8_99_1 doi: 10.1038/sj.onc.1210026 – ident: e_1_2_8_45_1 doi: 10.1111/j.1365-2559.1978.tb01698.x – ident: e_1_2_8_60_1 doi: 10.1016/S0002-9440(10)61166-2 – ident: e_1_2_8_68_1 doi: 10.1016/j.ccr.2005.07.009 – ident: e_1_2_8_71_1 doi: 10.1126/science.1094291 – ident: e_1_2_8_77_1 doi: 10.1007/s10585-004-3759-1 – ident: e_1_2_8_55_1 doi: 10.1093/ndt/17.suppl_9.65 – volume: 45 start-page: 5088 year: 1985 ident: e_1_2_8_66_1 article-title: An immunocytochemical and ultrastructural study of heterogeneity in the human breast carcinoma cell line P MC42 publication-title: Cancer Res contributor: fullname: Monaghan P – ident: e_1_2_8_87_1 doi: 10.1016/S0070-2153(08)60760-7 – ident: e_1_2_8_34_1 doi: 10.1159/000147748 – ident: e_1_2_8_79_1 doi: 10.1007/s00428-005-0118-9 – ident: e_1_2_8_6_1 doi: 10.1073/pnas.96.11.6249 – ident: e_1_2_8_27_1 doi: 10.1016/j.ceb.2007.02.007 – ident: e_1_2_8_69_1 doi: 10.1038/sj.onc.1209265 – ident: e_1_2_8_37_1 doi: 10.1073/pnas.012425299 – ident: e_1_2_8_16_1 doi: 10.1158/0008-5472.CAN-06-0410 – ident: e_1_2_8_20_1 doi: 10.1159/000084508 – ident: e_1_2_8_47_1 doi: 10.1016/j.cell.2004.07.011 – ident: e_1_2_8_33_1 doi: 10.1158/0008-5472.CAN-06-3689 – ident: e_1_2_8_24_1 doi: 10.1159/000147752 – ident: e_1_2_8_82_1 doi: 10.1073/pnas.91.12.5657 – ident: e_1_2_8_98_1 doi: 10.1159/000147847 – ident: e_1_2_8_96_1 doi: 10.1038/415530a – volume: 131 start-page: 205 year: 2007 ident: e_1_2_8_23_1 article-title: Epithelioid and epithelial neoplasms of bone publication-title: Arch Pathol Lab Med doi: 10.5858/2007-131-205-EAENOB contributor: fullname: Deyrup AT – ident: e_1_2_8_70_1 doi: 10.1242/jcs.003129 – ident: e_1_2_8_59_1 doi: 10.1186/bcr1656 – ident: e_1_2_8_75_1 doi: 10.1073/pnas.0603090103 |
| SSID | ssj0009933 |
| Score | 2.5333579 |
| SecondaryResourceType | review_article |
| Snippet | Like a set of bookends, cellular, molecular, and genetic changes of the beginnings of life mirror those of one of the most common cause of death—metastatic... Like a set of bookends, cellular, molecular, and genetic changes of the beginnings of life mirror those of one of the most common cause of death--metastatic... |
| SourceID | proquest crossref pubmed wiley istex |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 374 |
| SubjectTerms | Biomarkers - metabolism Breast Neoplasms Carcinoma - pathology Carcinoma - physiopathology Cell Line, Tumor Cell Transformation, Neoplastic Disease Progression Epithelial Cells - cytology Epithelial Cells - metabolism Epithelium - pathology Epithelium - physiology Female Humans Male Mesoderm - pathology Mesoderm - physiology Neoplasm Invasiveness Prostatic Neoplasms - pathology Prostatic Neoplasms - physiopathology |
| Title | Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression |
| URI | https://api.istex.fr/ark:/67375/WNG-LJSVKFTT-Q/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjcp.21223 https://www.ncbi.nlm.nih.gov/pubmed/17680632 https://search.proquest.com/docview/68228488 |
| Volume | 213 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwED9NnZB4YaNjW9gAC6GJl7TNXzfaU9W1TAUmYB1U0yTLdhMBXdNqayXK0z7EPuE-CXd201IE0sRbrDiO47uzf3bufgfwKvZ5hquwdokM3A09GbnS53TM4ekwVEnkxxSc_P4kPj4LO72otwaHRSyM5YdYHLiRZZj5mgxcquvqkjT0ux5XcN71ienTCzi58x19WlJHJfM08sYFIQq9glWo5lcXT66sRes0rD_-BjRXcatZeNobcFF02fqbDCrTiaron3-wOf7nN23CozkgZQ2rQY9hLc3LsNXIcTM-nLEDZlxEzdl7GR7YzJWzLThvjSmY4xK19-7mdkghTPrrbIgNybzPfivj3XRRlU1oZbROYuxbzjQlMspHQ8mMm5ilCHkCZ-1Wt3nsztM0uDpE8ORyqTjabhoFPEmxkNVCSbCRKxUoxJ913FTJvqolWgWa66yeaUm0gDJLYq2VF2xDKR_l6S4w3C7JWpJlmkiCUtwJIfTXXMk-orYY23LgZSEwMbZsHMLyLvsCx06YsXPgwIhyUUNeDch9jUfiy8kb8a5z-vltu9sVHx14UchaoFHRnxKZp6PptYgRNtVxanNgx6rA8m3YKUR1vgOvjSD_3Q3RaX4wF0_vX3UPHpqzYxPruA-lydU0fYagZ6KeG-3-Bdwr_qQ |
| link.rule.ids | 314,780,784,1375,27924,27925,46294,46718 |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bThsxEB1RUFVeaLmULr1gVQjxsiF7dVbiBVFCGkJES6BRpcqynV2VSzYRJBLpUz-iX9gv6YydTUpVJMTbWuv1ej0e-8zszDHARuzzDHdh7RIZuBt6MnKlz8nN4ekwVEnkx5ScfNSMa6dhvR21Z2CnyIWx_BAThxtphlmvScHJIb09ZQ290P0SLrx-8ATmUN09Cuj68HlKHpWMD5I3QQhR6BW8QmV_e_Lond1ojgb29n9Q8y5yNVtP9Tl8KzptI04uS8OBKukf__A5PvarXsDCGJOyXTuJFmEmzZdgeTdHe7w7YpvMRIka9_sSPLWHV46W4et-n_I5rnAC__75q0tZTPr7qIsNybzD_irj3XRSlQ1oc7RxYuw8Z5rOMsp7XclMpJhlCVmB0-p-a6_mjk9qcHWI-MnlUnFU3zQKeJJiISuHkpAjVypQCEEraFfJjionWgWa66ySaUnMgDJLYq2VF7yE2byXp6-AocUky0mWaeIJStEYQvSvuZIdBG4xtuXA-0Jiom8JOYSlXvYFjp0wY-fAppHlpIa8vqQINh6JL80D0aifnB1WWy3xyYH1QtgC9Yp-lsg87Q1vRIzIqYKrmwOrdg5M34adQmDnO7BlJHl_N0R979hcrD286jo8q7WOGqLxsXn4GuaNK9mkPr6B2cH1MH2LGGig3pmp_gfEEQLU |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZT-MwEB6VokW8AMsZTmuFEC_pkcuNeELQLhSo2KXsIoRk2W4irqYVtBLliR_BL-SXMLabFhBIq32LFcdxfM03k5lvANYDh8YohaWtyMBtr8h9mztUmTmK0vNE6DuBCk4-qgV7p171zD_LwFYaC2P4IQYGN7Uz9HmtNni7EeeHpKHXsp3Dc9dxR2DUC5xQEefv_h5yR4X9PPLaB8H3iimtUMHJDx59J4xG1bg-fIY03wNXLXkqk3CR9tk4nNzkuh2Rk48f6Bz_86OmYKKPSMm2WULfIRMl0zCznaA23uyRDaJ9RLXxfRq-mdSVvRk4L7dVNMctLt-Xp-emimGSl70mNsSTBnlTxrvRoCrpKNFovMTIVUKkymSUtJqcaD8xwxEyC6eVcn1nz-7nabAlDrxrUy4obt7Id2kYYSEueFzhRiqEKxCAllCr4g1RCKVwJZVxKZZc8QLyOAykFEV3DrJJK4kWgKC-xAthHEvFEhShKoTYX1LBGwjbAmzLgh_phLG2oeNghnjZYTh2TI-dBRt6Kgc1-N2N8l-jPvtb-8kOqyd_Dir1OvtlwVo61wx3lfpVwpOo1b1nAeKmEp5tFsybJTB8G3YKYZ1jwaaeyK-7wao7x_pi8d-rrsHY8W6FHe7XDpZgXNuRddzjMmQ7d91oBQFQR6zqhf4KxwkBgw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epithelial%E2%80%94mesenchymal+and+mesenchymal%E2%80%94epithelial+transitions+in+carcinoma+progression&rft.jtitle=Journal+of+cellular+physiology&rft.au=Hugo%2C+Honor&rft.au=Ackland%2C+M.+Leigh&rft.au=Blick%2C+Tony&rft.au=Lawrence%2C+Mitchell+G.&rft.date=2007-11-01&rft.issn=0021-9541&rft.eissn=1097-4652&rft.volume=213&rft.issue=2&rft.spage=374&rft.epage=383&rft_id=info:doi/10.1002%2Fjcp.21223&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_jcp_21223 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9541&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9541&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9541&client=summon |